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quality" of" life." " The" exact" mechanisms" causing" cough" in" IPF" remain" unclear,"
however"there"is"evidence"that"altered"cough"neurophysiology"and"sensitisation"
plays" a" roleY" IPF" patients" have" an" enhanced" cough" reflex" sensitivity" to" the"
inhalation"of"capsaicin.""
It"was"hypothesised"that"IPF"patients"have"increased"airway"expression"of"the"
capsaicin" receptor" TRPVF1" and" a" coFexpressed" receptor" TRPAF1." Bronchial"
biopsies" were" obtained" in" 16" IPF" patients," 11" chronic" cough" patients" and" 8"








































































































































































































































































































































































































































































al." 2015)" and" has" no" cure." There" are" currently" very" few" treatments" that" are"











of" rapidly" fatal" diffuse," idiopathic" pulmonary" fibrosis" in" four" patients" in" 1935"
(Hamman"and"Rich"1935Y"Homolka"1987)."The"term"‘HammanFRich"Syndrome’"
was"subsequently"applied,"and"despite"the"acute"onset"and"rapid"progression"of"
disease" observed" in" this" series" this" is" what" many" clinicians" associated" with"
idiopathic"pulmonary"fibrosis"for"several"decades"(Noble"and"Homer"2005).""Over"
time" it" became" recognised" that" there" were" a" variety" of" potential" aetiological"
factors" or" associations" such" as" connective" tissue" diseases," environmental"
exposures" and" drugs," however" there" remained" cases" that" appeared" to" be"










of" idiopathic" interstitial" lung" disease" (Liebow" 1969)." Using" experience" of"
histological" patterns" they" were" able" to" divide" interstitial" pneumonias" into" five"
distinct" groupsY" ‘usual’" interstitial" pneumonia" (UIP)," desquamative" interstitial"
pneumonia" (DIP)," bronchiolitis" obliterans" with" interstitial" pneumonia" (BIP),"
lymphoid"interstitial"pneumonia"(LIP),"and"giant"cell"interstitial"pneumonia"(GIP)."
At" this" time" ‘HammanFRich" Syndrome’" was" considered" an" acute" form" of" UIP"




Other" histological" subtypes" were" described" which" resulted" in" a" revised"
histopathological"classification" in"1998"by"Katzenstein"and"Myers"(Katzenstein"
and" Myers" 1998)." Their" classification" includes" five" histopathologically" distinct"
subgroups:"UIP,"which"they"felt"was"the"‘characteristic"pattern"of"IPF’Y"DIP"now"

































improve" communication" between" clinicians" across" the" world" but" would" also"








complete" removal" of" the" term"CFA," acceptance" of" NSIP" as" a" distinct" clinical"
entity,"thus"removing"its"previous"provisional"status"and"the"inclusion"of"idiopathic"
pleuroparenchymal" fibroelastosis" (PPFE)Y" a" rare" IIP" characterised" by"
predominantly" upper" lobe" fibrosis" involving" the" pleura" and" subFpleural" lung"
parenchyma." Figure" 1" outlines" the" current" classification" and" its" chronological"
development."
"
The"ATS/ERS"defines" IPF"as," ‘a"distinctive" type"of"chronic" fibrosing" interstitial"
pneumonia"of"unknown"cause"limited"to"the"lungs"and"associated"with"a"surgical"
lung"biopsy"showing"a"histological"pattern"of"UIP."Other"causes"must"have"been"
excluded" and" clinical" findings" must" correlate.’" Consensus" criteria" for" the"







# # Diffuse'Parenchymal'Lung'Diseases/'Interstitial'Lung'Diseases# #





# Idiopathic'interstitial'pneumonias'(IIPs)' # Granulomatous#conditions#i.e.#sarcoidosis# #
Miscellaneous#i.e.#LAM,#
#Histiocytosis#X#

















Fibrosing## # NSIP# # NSIP##(NSIP#pattern)#
#




















Acute## # # # LIP#(LIP#pattern)#
#









# AIP# # AIP##(Diffuse#alveolar#haemorrhage)#
#
'



















7W16# per# 100,000# personWyears# in# the# USA# (Raghu# et# al.# 2014).# A# study# by#
Navaratnam# et# al.# estimated# a# 5%# annual# increase# in# the# incidence# of# IPF#
(Navaratnam# et# al.# 2011).# In# general,# European# and# Asian# prevalence# and#
incidence# estimates# appear# to# be# lower# relative# to# those# reported# in# the# US#
populations,#although#it#remains#unclear#whether#these#are#true#differences#or#as#









































































a# statistically# significant# association# between# cigarette# smoking# and# the#








Initial# evidence# suggested# that# current# smokers# had# a# survival# advantage#
compared# to# former# smokers# and# never# smokers# (King# et# al.# 2001b).# More#
recently#however#Antoniou#et#al#reported#that#lifeWlong#nonWsmokers#have#a#better#
outcome#than#former#smokers#as#well#as#former#smokers#and#current#smokers#










dust# (OR:# 2.44)# and# Stone# dust# (OR:# 1.97)# showed# an# increased# risk# of#





Evidence#suggests# that#genetic# factors#predispose# to# the#development#of# IPF,#
with# familial# cases# presenting# the# most# convincing# evidence# for# a# genetic#
predisposition,# with# numerous# reports# of# familial# clustering# and# disease# in#
monozygotic#twins#raised#in#different#environments#(Peabody#and#Hayes#1950J#
Hughes# 1964J# Hodgson# et# al.# 2002).# The# mode# of# genetic# transmission# of#
susceptibility# to# pulmonary# fibrosis# in# familial# cases# is# likely# to# be# autosomalW
dominant#with#incomplete#penetrance#(Musk#et#al.#1986J#Steele#et#al.#2005).#The#
exact# prevalence# of# familial# pulmonary# fibrosis# is# unknownJ# however# studies#












genes# involved# in# telomere# length# maintenance# have# also# been# studied.#
Dyskeratosis#congenita#is#a#disease#characterised#by#telomerase#dysfunction#and#













number# of# genes,# identifying#genetic# polymorphisms.#A# recent# link# between#a#
polymorphism#in#the#promoter#of#the#gene#encoding#a#mucin#(MUC5B)#and#IPF#
has#been#established# (Cronkhite#et#al.#2008J#Seibold#et#al.#2011J#Zhang#et#al.#





genomeWwide# association# studies# (GWAS)# (Fingerlin# et# al.# 2013J# Noth# et# al.#
2013).#The#role#of#MUC5B#in#the#development#of#IPF#remains#unclear,#however#
as#mucins#provide#barrier#protection#and#are# important# in# innate# immunity# it# is#
believed#that# immune#dysregulation#or#abnormal#mucin#expression#may#play#a#
role#(Parker#and#Prince#2011J#Plantier#et#al.#2011).#Despite#the#association#of#this#
polymorphism# with# increased# susceptibility,# a# number# of# researchers# have#
identified# that# its# presence# is# also# associated# with# a# more# favourable# IPF#
phenotype#(Yang#et#al.#2013),#an# improved#survival# (Peljto#et#al.#2013),#and#a#
trend# to# a# slower# decline# in# FVC# (Stock# et# al.# 2013).# Interestingly# another#
polymorphism#in#the#gene#for#TOLLIP#(TollWinteracting#protein),#has#been#found#






It# is# likely# that# combinations# of# polymorphisms# and# environmental# exposures#
result#in#different#gene#expression#profiles#which#may#influence#susceptibility#and#










The# discovery# of# polymorphisms# in# genes# controlling# innate# immunity# has#





Extensive# research# has# also# been# performed# to# investigate# a# possible# viral#
aetiology#of#IPF,#as#recently#summarised#by#Moore#et#al#(Moore#and#Moore#2015).#
The# human# herpes# virusesJ# specifically# EpsteinWBarr# virus# (EBV)# has# been#
implicated.#Several#studies#have#reported#an#increased#rate#of#detection#of#the#
virus#in#patients#with#IPF#(Vergnon#et#al.#1984J#Stewart#et#al.#1999J#Manika#et#al.#
2007).# Vergnon# and# colleagues# first# made# the# association# in# a# study# which#
identified#raised#serum#Immunoglobulin#A#(IgA)#levels#against#viral#capsid#antigen#
(VCA)#in#IPF#patients#compared#with#controls#(Vergnon#et#al.#1984).##Egan#et#al.#





causal# link.# However,# a# recent# study# looking# at# asymptomatic# firstWdegree#
relatives# of# patients# with# familial# interstitial# pneumonia# (FIP)# has# provided#
supportive#evidence.#Kropski#et#al.#found#increased#herpesvirus#DNA#and#antigen#
expression# in# alveolar# epithelial# cells# in# family# members# at# risk,# and# this#
correlated#with#evidence#of#endoplasmic#reticulum#stress#(Kropski#et#al.#2015).#
Tsukamoto#and#colleagues#have#also#found#that#EBV#can#be#associated#with#a#







Other# viral# infections# such# as# hepatitis# C# and# adenovirus# have# also# been#










et# al.# 2006aJ# Sweet# et# al.# 2007J# Noth# et# al.# 2012).# Despite# evidence# of# an#







2.22,# 95%# CI# 1.89W2.60)# (Gribbin# et# al.# 2009).# This# study,# although# caseW







did# not# find# a# significant# correlation# between# the# degree# of# fibrosis# and# the#
number#of#reflux#episodes#in#nonWIPF#patients#with#pulmonary#fibrosis#as#it#did#in#
IPF#patients,#which#provides#evidence#to#suggest#that#GOR#in#IPF#patients#may#
not# be# the# consequence# of# pulmonary# stiffness# and# reduced# compliance#
(Savarino#et#al.#2013).##
#














colleagues# found# that# when# compared# with# nonWIPF# ILD# patients# and# normal#
controls,#IPF#patients#had#increased#weakly#acid#episodes#of#GOR#in#the#distal#











role# in# acute# exacerbations# of# IPF.# Lee# and# colleagues# detected# pepsin,# a#






al.# 2012J#Raghu#and#Meyer#2012).#A#study#by#Tcherakian#et#al.# supports# this#
having#recently#found#that#patients#with#asymmetrical#disease#were#more#likely#to#














2011),# and# a# subsequent# study# demonstrated# patients# who# received# antacid#








2016).# LongWterm,# randomisedWcontrolled# trials# are# needed# to# investigate# this#
further.#
#










IPF# and# although,# typically# progressive,# the# rate# of# progression# in# individual#







IPF# and# its# link# to# the# pathogenesis# remain# unclear.#Constitutional# symptoms#










uniform'swelling'of' the'soft' tissues'of' the'terminal'phalanx’,# is#also#a#common#
feature,#being#present#in#up#to#50%#of#cases#(Shneerson#1981J#Meltzer#and#Noble#
2008).# Former# or# current# smokers# are# more# likely# to# have# clubbing# as# a#
presenting#feature#(Schwarz#and#King#2010).#Patients#may#appear#dyspnoeic#at#








The# possible# findings# on# investigation# are# outlined# below.# Current# guidelines#







usually# monitored# at# regular# intervals# to# assess# the# need# for# supplemental#
26#
#
oxygen.# Unlike# other# conditions# causing# chronic# hypoxia,# erythrocytosis# is#






of# the# data# as# they# were# undertaken# prior# to# the# currently# appreciated#
classification#of# IPF# (Crystal# et# al.# 1976J#TurnerWWarwick#et# al.# 1980).#Recent#
studies# show# the# frequency# of# circulating# autoWantibodies# to# be# similar# in# IPF#










Recent# studies# have# investigated# the# possible# link# between# the# coagulation#
cascade#and#the#pathogenesis#and#or#treatment#of#IPF.#A#large#population#based#
study#in#the#UK#identified#that#IPF#patients#were#significantly#more#likely#to#have#
a# proWcoagulant# state# compared# with# controls# and# those# with# two# or# more#
coagulation#defects#had#an#increased#risk#of#death#(Navaratnam#et#al.#2014)#A#
study#by#Bargagli#et#al#showed#that#this#proWcoagulant#state#is#more#evident# in#
those# with# an# acute# exacerbation# compared# to# patients# with# stable# disease#










lung# volumes,# however# due# to# increased# elastic# recoil# maintaining# the# static#
airway#dimensions#flow#rates#are#often#higher#than#expected#for#the#given#lung#
volume.# # As# the# FEV1# and# FVC# are# reduced# in# proportion# to# the# other,# the#
FEV1/FVC#ratio# is#maintained,# resulting# in#a# restrictive#picture#as# illustrated# in#




the# fibrotic# process# the# total# lung# capacity# (TLC),# functional# residual# capacity#
(FRC)# and# residual# volume# (RV)# often# become# reduced# proportionally.# The#




normal# or# decreased# due# to# fibrosis# causing# increased# radial# traction# on# the#
airways#at#an#often# lower# lung#volume# resulting# in# larger#airway#calibre# (West#
2013).##
#
Gas#exchange# is#abnormal# in# IPF#patients#with#a#reduced#arterial#PO2#and#an#
elevated#alveolarWarterial#oxygen#tension#gradient#(P#(AWa)#O2).#PH#and#Pco2#are#
usually# normalJ# however# Pco2# can# be# reduced# as# a# consequence# of# alveolar#
hyperventilation.# In# terminal# respiratory# failure# the# Pco2# may# rise# causing# a#
reduction#in#pH.##
#













Baseline# spirometry# may# be# helpful# in# predicting# prognosisJ# however# serial#
measurements# have# been# more# reliably# associated# with# mortality.# # Several#





6W12#month#period#also#predicts# a#worse# survival,# although# this# has#not# been#
found#consistently#(Mogulkoc#et#al.#2001J#Flaherty#et#al.#2003aJ#Egan#et#al.#2005J#




































! ! ! Normal#(A)#and#restrictive#(B)#patterns#of#a#forced#expiration.#



































! ! ! Pressure)volume#curves#of#the#Lung.#Note#the#flattened#curve#for#interstitial#fibrosis#
































was#due# to#V/Q#mismatch#with#20%#due# to#a#diffusion# impairment#of#oxygenV#
however,#during#exercise#these#figures#were#60%#and#40%#respectively#(Agusti#













A#chest# radiograph#may#be#normal# in#early# IPF,#however# it# is#abnormal# in# the#
majority#of#patients#with#interstitial#lung#disease#(Epler#et#al.#1978).#An#abnormal#
chest#XGray#may#be#an#incidental#finding#in#an#asymptomatic#patient#or#the#first#
investigation#alerting# the#physician# to# the#possibility#of#a#diagnosis#of# IPF# in#a#
patient#presenting#with#dyspnoea#or#cough#(Baughman#and#Du#Bois#2004).#The#
classical#radiographic#finding#in#patients#with#IPF#is#bilateral#reticular#shadowingV#
linear# or# curvilinear# densities# which# form# a# netGlike# pattern# (figure# 5).# Less#
commonly,#nodular#opacities#are#seen#and#the#pattern#is#described#as#reticuloG
nodular# (McLoud# et# al.# 1983).# The# distribution# is# typically# diffuse# with# a# subG






radiographic# changes# are# often# associated# with# evidence# of# reduced# lung#

























in# Figure# 6.#Characteristically# on#HRCT# there# is# a# subGpleural,# basal# reticular#
pattern#which#is#often#patchy#and#can#be#asymmetrical#(Tcherakian#et#al.#2011).#





spaces,#which#have#wellGdefined#walls#which#vary# in# size# from#3mm# to#2.5cm#
(Meziane#et#al.#1988V#Hansell#et#al.#2008).##
#
Ground# glass# opacification# seen# as# a# ‘hazy# increased# opacity# of# the# lung’# on#
HRCT#is#common#but#is#usually#in#combination#with#the#reticular#pattern#and#is#
less#prominent#than#the#latter#(Hansell#et#al.#2008V#Hansell#et#al.#2010).#If#ground#
glass# is# seen# in# isolation# or# is# the# predominant# abnormality,# an# alternative#
diagnosis#should#be#considered.##
#
Small# volume# (<# 15mm)# lymphadenopathy# is# seen# in# more# than# half# of# IPF#
patients#on#HRCT#scanning.#The#most# frequently# affected#nodal# stations# vary#
between# studies.# No# correlation# has# been# found# between# the# presence# of#

































criteria# for# a# definite# UIP# pattern,# possible# UIP# pattern# and#
described# a# pattern# inconsistent# with# UIP.# All# patients# without# a#






HRCT# also# allows# the# diagnosis# and# appreciation# of# the# extent# of# coGexisting#
COPD#more# accurately# than# CXR# (Wiggins# et# al.# 1990).# This# is# important# to#
recognise# as# Akira# et# al# identified# that# because# emphysematous# change# can#
sometimes# mimic# honeycombing,# concurrent# emphysema# on# scanning# can#











Several# studies# have# shown# that# over# time# the# extent# of# honeycombing# and#



















































in#most# patients,# including# those#who# are# critically# unwell# (Hertz# et# al.# 1991).#
Fever# has#been# found# to# occur#more# commonly#with#BAL# than#bronchoscopy#
alone# and# # exacerbation# of# IPF# has# been# observed,# with# frequency# varying#
between#case#series#(Hiwatari#et#al.#1994R#Honeybourne#et#al.#2001R#Kim#et#al.#
2006a).#One#series#reported#3#exacerbations#in#124#patients#that#underwent#BAL#
(Hiwatari# et# al.# 1994).# BAL# cellular# analysis# in# patients# suspected# of# IPF# but#
without#characteristic#HRCT#findings#may#help#narrow#the#differential#diagnosis#














also#showed# that#neutrophilia#had#no#prognostic# role# in# IPF# (Ryu#et#al.#2007).#





Lymphocytosis# ># 15%# is# not# a# feature# of# UIP.# Historically# however# BAL#
lymphocytosis# was# thought# to# have# been# a# good# prognostic# factor# in# UIP.#
Following# the# re]classification# and# description# of# NSIP,# it# is# thought# that#
misclassification#occurred#and#BAL# lymphocytosis# is#more# likely#suggestive#of#
NSIP#rather#than#UIP.#Veeraraghavan#and#colleagues#argued#against#this#as#they#
failed#to#identify#any#difference#in#BAL#cell#counts#in#patients#with#IPF#and#NSIP#
(Veeraraghavan# et# al.# 2003).# A# subsequent# larger# study# however,# found# a#
significantly#higher#BAL#lymphocyte#count#in#patients#with#surgically#proven#NSIP#
compared#with#UIP,#and#those#with#NSIP#and#lymphocytosis#had#a#significantly#










and#more# importantly#hypersensitivity#pneumonitis# (lymphocytes# typically#>#40#
%.)# A# recent# study# showed# that# BAL# improved# the# accuracy# of# diagnosis# in#
patients#with#suspected#IPF#(Ohshimo#et#al.#2009R#Raghu#et#al.#2011).#Current#

























leading# edge# of# a# complex# reticulum# which# extends# between# the# pleura# and#
underlying# parenchyma# (Agusti# 2002R# Cool# et# al.# 2006).# Fibroblastic# foci# are#






associated#with# fibrotic# scar# tissue# and# areas# of# smooth#muscle# hypertrophy.#
Lymphocytes,#plasma#cells,#and#hyperplastic,#hypertrophied#type#II#alveolar#cells#
and# bronchiolar# epithelial# cells# makeup# the# patchy# alveolar# infiltrate,# often#




as# histo]pathological# variability# has# been# found# in# biopsies# from# individual#
patients,#and#has#prognostic#implications#(Flaherty#et#al.#2001R#Monaghan#et#al.#
2004).# Current# guidelines# also# provide# criteria# for# a# definite,# probable# and#
possible# UIP# pattern# on# histopathological# examination# (figure# 10).# These#



































































Adapted' from# (Raghu# et# al.# 2011).# The# current# guidelines# have#






The# most# recent# ATS/ERS# consensus# statement# on# the# diagnosis# and#
management# of# IPF# has# emphasised# the# importance# of# a# multidisciplinary#
discussion# between# respiratory# physicians,# radiologists,# and# pathologists#



















































withdrawal#of# futile# therapies#and#end=of=life#care#be#considered#at# the# time#of#
diagnosis#and#be# tailored#specifically# to# the#needs#of# the#patient# (NICE#2013).#
There#has#not#been#a#prospective#study#investigating#the#use#of#oxygen#in#IPF#
however#its#use#is#recommended#when#there#is#resting#hypoxia,#as#evidence#for#
the# use# of# oxygen# has# been# extrapolated# from# studies# showing# a# significant#
survival#benefit#in#COPD#patients#using#long=term#oxygen#therapy#(Raghu#et#al.#







a# thorough# review# published# by# Rafii# et# al# (Rafii# et# al.# 2013).# Therapeutic#
strategies# originally# targeted# the# process# of# inflammation,# whereas# current#
strategies#are#primarily#focused#on#the#fibrotic#process.##
#
Since#April# 2013,# Pirfenidone# (Esbriet,# InterMune)# has# been# endorsed# by# the#
National#Institute#for#Health#and#Care#Excellence#(NICE)#for#the#treatment#of#IPF#
in#patients#with#a#FVC#between#50=80%#provided#they#have#yearly#follow=ups#and#
no# evidence# of# disease# progression# (reduction# in# FVC# by# 10%)# whilst# on#
treatment.#The#exact#mechanism#of#action#is#unclear,#but#it#is#believed#to#be#an#
anti=fibrotic#agent#(NICE#2013).#Four#large#phase#III#randomised#controlled#trials,#
three# of# which#were#multi=national,# demonstrated# a# reduction# in# lung# function#
decline,#all=cause#mortality#at#one#year#and#an#improved#progression=free#survival#
(Taniguchi#et#al.#2010M#Noble#et#al.#2011M#King#et#al.#2014).#More#recent#studies#






Another# new# agent#was# also# recently# endorsed# by#NICE# in# the# same# patient#
group#(NICE#2016).#Nintedinib,#is#an#intracellular#inhibitor#which#targets#a#number#
of#tyrosine#kinases#that#have#been#implicated#in#the#pathogenesis#of#IPF,#namely#








of# life#and# time# to# first#acute#exacerbation#however,#with# INPULSIS# I# failing# to#
show# an# increased# time# to# first# exacerbation# or# a# slowing# of# deterioration# of#
quality#of#life.#Also#although#the#authors#report#the#drug#as#having#an#acceptable#
tolerability#profile,#they#report#diarrhoea#in#over#60%#of#patients#(Richeldi#et#al.#
2014).# Both# drugs# are# only# recommended# if# the# manufacturer provides the 












have#been# identified.#The#most#effective#method# for#staging# IPF#has#yet# to#be#
established.#Despite#new#therapeutic#strategies#the#prognosis#for#the#majority#of#
patients#with# IPF#remains#poor#with#a#median#survival#of# less# than#4#years.# In#
clinical# practice# the# rate# of# decline# varies# between# individuals# with# some#

























































































finding# in# patients# with# IPF,# with# alternating# areas# of# fibrosis,# honeycombing,#
interstitial# inflammation# and# normal# lung.# Despite# the# consistently# observed#
features#of#epithelial#disruption,#collagen#deposition#and#presence#of#fibrotic#foci#





The#theory#of# IPF#pathogenesis,#developed# in# the#1970=1980’s#suggested#that#
IPF#was#the#result#of#a#chronic#inflammatory#response#to#an#unknown#stimulus#
that# caused# lung# injury# and#progressive# fibrosis.#This# theory#was#based#upon#
several# observations.# Early# studies# of# bronchoalveolar# lavage# fluid# found# IPF#
patients#had#increased#number#of#inflammatory#cells#compared#to#patients#with#
normal# lung# function# (Merrill# and# Reynolds# 1983M# Reynolds# et# al.# 2005).# An#
increased#number#of#neutrophils#and#activated#macrophages#were#also#observed#








IPF# has# since# been# questioned.# Several# pieces# of# evidence# suggested# the#
observations#that#formed#the#basis#of#the#theory,#as#outlined#above,#were#invalid.#
The# pathological# classification# of# IPF# in# 1998# by# Katzenstein,# highlighted# a#
paucity#of#inflammation#in#early#disease,#and#yet#was#in#association#with#areas#of#
collagen# deposition# and# honeycombing,# suggesting# underlying# fibrosis#















increased# all=cause#mortality# (Raghu# et# al.# 2012).# This# arm# of# the# study#was#






The# ‘epithelial’# hypothesis# has#been#proposed#as#an#alternative# theory#of# IPF#
pathogenesis.#It#is#currently#believed#that#the#fibrotic#process#in#IPF#is#a#result#of#




of# cellular,# immune# and# coagulation# pathways,# which# are# co=ordinated# by# a#
variety#of#soluble#mediators#such#as#growth#factors,#chemokines,#interleukins#and#
prostaglandins.# This# interaction# results# in# rapid# restoration# of# the# epithelial#
integrity#via#migration,#differentiation#and#proliferation#of#epithelial#cells#allowing#
re=epithelialisation#and#re=endothelialisation.#Extra=cellular#matrix#is#deposited#as#
part#of# the#normal#healing#process,#but# is# reabsorbed# following#removal#of# the#













disruption# to# the# alveolar=capillary# basement# membrane.# This# has# been#
demonstrated# using# electron# microscopy# (Katzenstein# 1985M# Harrison# et# al.#
1991).##
#
Alveolar# epithelium# in# the# normal# lung# is# comprised# of# predominantly# type# I#
alveolar#epithelial#cells#(AECs),#with#a#smaller#number#of#type#II#AECs.#Following#
alveolar# epithelium# injury,# type# II#AECs#proliferate#and#differentiate# into# type# I#
AECs,#thus#repairing#the#alveolar#epithelium#(Crapo#et#al.#1982M#Castranova#et#al.#
1988).#In#IPF,#loss#and/or#damage#to#type#I#cells#and#proliferation#of#type#II#cells#













basement# membrane# is# a# complex# structure# of# type# IV# collagen,# laminin,#
perlecan,#and#entactin.#The#cause#of#membrane#disruption#is#not#fully#understood#
but#loss#of#alveolar#epithelium#allows#enzymes#produced#by#a#variety#of#lung#cells#
to#have#contact#with#and#degrade#components#of# the#membrane.# #The# loss#of#
basement#membrane# integrity#results# in# its# failure#to#provide#structural#support#
and#act#as#a#barrier,#which#regulates#cellular#processes.#This#may#contribute#to#
the# failure# of# re=epithelialisation# and# allow# migration# of# fibroblasts# and#










































factor# β# (TGF=β),# tumour# necrosis# factor# α# (TNF# α),# endothelin=1,# connective#
tissue#growth#factor,#and#osteopontin#(Antoniades#et#al.#1990M#Nash#et#al.#1993M#
Pardo#et#al.#2005M#Selman#and#Pardo#2006).#Epithelial#injury#also#activates#the#
coagulation# cascade#which# has# several# pro=fibrotic# effects# (Borensztajn# et# al.#




Fibroblasts# when# activated#migrate# to# the# site# of# injury,# and# along#with# other#
mesenchymal#cells#including#myofibroblasts#become#organised#into#fibroblastic#
foci.#These# foci# represent#active#areas#of# fibrosis#and#are#situated#adjacent# to#





Several# sub=populations# of# fibroblasts# are# present# in# IPF.# The# pro=fibrotic#
environment# induced# by# the# injured# epithelial# cells# is# thought# to# induce# these#
changesM#with#the#injured#alveolar#epithelium#seen#as#the#leading#edge#of#active#

















Myofibroblasts# are# activated# mesenchymal# cells# that# have# the# combined#
properties# of# fibroblasts# and# smooth#muscle# cells.# They# secrete# extra=cellular#
matrix#but#also#have#contractile#ability# through#expression#of#α=smooth#muscle#
actin#(α=SMA)#(Kuhn#and#McDonald#1991M#Hinz#et#al.#2007).#Via#cell#contraction#
















pro=fibrotic# mediator# in# the# interaction# between# AECs,# fibroblasts# and#
myofibroblasts#(Khalil#et#al.#1991M#Wuyts#et#al.#2013).#This#cytokine#promotes#the#
differentiation#of# fibroblasts# into#myofibroblasts,# induces# the#secretion#of#extra=
cellular# matrix# and# has# also# been# shown# to# inhibit# collagen# degradation# and#
myofibroblast# apoptosis,# which# leads# to# an# accumulation# and# persistence# of#
extracellular#matrix#(Zhang#and#Phan#1999M#Hong#et#al.#2007M#Wuyts#et#al.#2013).#
#
Activated# fibroblasts# and# myofibroblasts# may# also# contribute# to# AEC# injuryM#
Angiotensin# II,# reactive# oxygen# species# and# their# interaction# with# the# pro=










matrix# and# has# a# constant# turn=over# which# is# tightly# regulated# to# ensure# the#
preservation# of# normal# lung# structure# and# function.# Fibroblasts# and#
myofibroblasts#have#a#key#role#in#ECM#synthesis#and#re=modelling.#Extracellular#
matrix# is# degraded# via# proteolysis# by# a# family# of# matrix# metalloproteinases#
(MMPs)# which# are# secreted# by# fibroblasts,# epithelial# cells,# neutrophils,# and#
macrophages.# Endogenous# inhibitors# known# as# tissue# inhibitors# of#










Neovascularisation# following# tissue# injury# is# another# process# that# is# tightly#
regulated#by#stimulatory#(angiogenic)#and#inhibitory#(angiostatic)#growth#factors.#
Studies#of#this#process#in#IPF#have#yielded#conflicting#results.#There#appears#to#











the# characteristic# fibroblast# proliferation,# collagen# deposition# and# architectural#
distortion.#Current#therapeutic#strategies#are#focused#on#fibrotic#processes.#
#
Although# our# understanding# of# the# basic# mechanisms# involved# in# the# fibrotic#
process# in# IPF# has# greatly# improved,# the# prognosis# remains# poor.# Symptom#
control#is#a#frequently#adopted#strategy.#The#pathogenesis#of#cough,#a#debilitating#
symptom# in# IPF# remains#unclear,#meaning# treatment# options#are# limited.#This#
symptom#suggests#that#there#is#an#abnormality#of#pulmonary#innervation#in#IPF#























The# human# lung# is# an# endoderm=derived# organ# that# develops# as# a# ventral#
outgrowth# of# the# foregut# during# the# embryonic# stage.# This# diverticulum# grows#
caudally#and#divides,# forming# the#primitive# trachea#and# lung#buds# (Laudy#and#
Wladimiroff# 2000).# Lung# neurons# arise# from# neural# crest# cells# which# have#
migrated# to# the# embryonic# foregut,# and# subsequently# to# the# developing# lungs#
(Burns# et# al.# 2008).# This# process# occurs# in# close# association# with# lung#







(sympathetic# and# parasympathetic)# pathways,# otherwise# known# as# the#
adrenergic#and#cholinergic#pathways#respectively,#there#is#a#non=adrenergic,#non=
cholinergic#system,#which# remains#poorly#defined# (Barnes#1984M#Undem#et#al.#




















































































































they#are#sparse# in#airway#smooth#muscle#and# therefore#have#very# little,# if#any#
influence# on# bronchial# airway# calibre# (Barnes# 1990M# Undem# et# al.# 1999).#




Although# adrenergic# fibres# are# poorly# represented# in# the# human# lung,# it# is#
believed# that# they#may# have# an# indirect# effect# on# these# neural# processes# via#
modulation#of#the#parasympathetic#pathway,#and#circulating#catecholamines#may#






travel# down# the# vagus# nerve,# which# joins# the# pulmonary# plexus.# The# fibres#
synapse#with#postganglionic#fibres#at#ganglia#situated#along#the#vagal#nerve#and#
in# the#airways.#The#parasympathetic#ganglia#are#situated# in# the# larger#airways#
and# the# postganglionic# fibres# supply# bronchial# smooth#muscle,# bronchial# and#







Acetylcholine,# released# by# cholinergic# fibres# binds# to# nicotinic# acetylcholine#





constriction#and#mucus# secretion,# providing# further# evidence# for# this# pathway.#
Pre=junctional#M2# receptors#are#believed# to#serve# to# limit#cholinergic#broncho=
constriction# and# when# activated# do# so# by# inhibition# of# acetylcholine# release.#










Despite# knowledge# of# the# embryological# development# of# the# lungs# and# the#
confirmed#presence#of#this#pathway#in#the#gastro=intestinal#tract,#NANC#was#not#
described#in#the#lung#until# the#1980’s#(Richardson#1981M#Barnes#1984).#This#is#
the#only#neurally=mediated#bronchodilator#pathway#given# the# lack#of# functional#
sympathetic# postganglionic# fibres# in# the# lung,# as# outlined# above.# In=vitro#










airways# (Ward# et# al.# 1995M# Fischer# and#Hoffmann# 1996).# The# exact# role# and#
contribution#of#these#and#possibly#other#neurotransmitters#remains#unclear.#Initial#
studies#suggested# that# this#pathway#was#associated#with# the#parasympathetic#
nerve#supply#to#the#lungM#it#was#thought#that#VIP#and#NO#were#released#from#post=
ganglionic#parasympathetic#nerves#along#with#acetylcholine.#Subsequent#studies#











originate# from# the# dorsal# root# ganglion# of# the# spinal# cord# # in# association#with#
sympathetic# fibres,# but# this# is# of# uncertain# significance# (Undem# et# al.# 1999).#
Afferent#fibres#arise#from#receptors#within#the#airway#epithelium,#smooth#muscle,#
sub=epithelial# tissue,# the# large# airway# perichondrial# area,# alveolar# tissue# and#
pulmonary# and# bronchial# blood# vessels# (Qutayba# and# Hamid# 2005).# The# cell#
bodies#of#vagal#afferent#fibres#are#within#the#vagal#sensory#gangliaM#the#jugular#
(superior#vagal)#or#nodose# (inferior#vagal)#ganglia#are#situated#on# the#cervical#





















information# on# lung# volume# and# transpulmonary# pressure# to# the# respiratory#
centre.#They#were#originally#described#following#the#observation#that#an#increase#
in#airway#wall#tension#resulted#in#increased,#regular#receptor#discharge#but#this#




sustained# inspiration,# and# at# high# lung# volumes# prolongs# expiration# (Barnes#
1990).# In# addition# to# responding# to# changes# in# airway# wall# tone,# they# are#
stimulated# by# histamine# and# acetylcholine# and# inhibited# by# CO2.# Stimulation#
results#in#reflex#bronchodilatation#by#inhibition#of#vagal#tone#(Widdicombe#2001).#
#











Rapidly# adapting# receptors# (RARs)# are# also#myelinated# fibres,# but# differ# from#
SARs#in#that#upon#stimulation#they#fire#irregularly#and#adapt#quickly#to#a#sustained#
mechanical#stimulus#such#as#is#present#at#the#end#of#inspiration.#They#are#able#to#
respond# to# airway# mechanical# changes# and# their# activity# during# respiration#
depends# upon# the# respiration# rate# and# inspiratory# volume# (Canning# 2006).#
63#
#
Stimulation#of# these# irritant# receptors#causes#bronchoconstriction#and#mucous#
secretion#by#a#reflex#increase#in#parasympathetic#efferent#activity.##
#
In#addition# to# their#mechanoreceptor#properties# they#are#also#chemoreceptors,#
stimulated# by# a# variety# of# chemical# stimuli,# inflammatory# and# immunologic#
mediators,#and#inhaled#particles#(Santambrogio#1982M#Widdicombe#2001).#RARs#
however,# are# relatively# insensitive# to# direct# chemical# stimuli# so# it# is# likely# that#
increased# RAR# activity# is# a# result# of# the# mechanical# consequences# of#
bronchoconstriction# and# obstruction# from# excess# mucus# secretion# evoked# by#
substances# such# as# capsaicin,# the# compound#which# gives# chilli# peppers# their#
heat,#and#substance#P.#In#support#of#this#argument#is#the#observation#that#RAR#
discharge# can# be# inhibited# by# preventing# mucous# secretion# and#
bronchoconstriction#(Canning#et#al.#2006).#
#
RARs# were# originally# reported# to# be# intra=# and# extra=pulmonary,# with# extra=
pulmonary#RARs#having#two#subtypesM#tracheal/bronchial#RARs#and#intermediate#
receptors# that# had# properties# suggestive# of# both# SARs# as# well# as# RARs#





these# findings# and# suggest# that# the# extra=pulmonary# afferent# neurones# are# a#
unique#subset,#not#readily#classifiable#as#RARs,#SARs#or#C=fibres#(Canning#et#al.#
2004).# The# electrophysiological# experiments# by# Canning# et# al.# identified# the#
presence#of#afferent#neurones#originating#in#the#nodose#ganglia#that#conducted#
action#potentials#in#the#Aδ#range#and#were#highly#sensitive#to#mechanical#stimuli#
and# acid# but# insensitive# to# capsaicin# and# bradykinin.# The# authors# identified#
differences# between# these# Aδ# fibres# and# the# pulmonary# RARs# and# SARs,#
suggesting# that# they#may# have# originally# been# poorly# classified# (Canning# and#
Chou#2009).#In#contrast#to#pulmonary#RARs,#the#re=defined#fibres#were#found#to#
have# a# slower# action# potential# conduction# velocity,# no# response# to# lung#






dogs# and# cats# that# did# respond# to# lung# distension# and/or# smooth# muscle#
contraction# suggest# that# this# unique# subset#may#not# be#present# in# all# species#
(Schelegle#and#Green#2001M#Widdicome#2003).#Canning#et#al.#suggest#that#these#







pulmonary# C=fibres,# (previously# termed# J=receptors)# are# situated# in# the#





As# well# as# having# differing# locations# within# the# airway# these# two# groups# of#
afferents# were# also# found# to# have# different# sensitivities# to# chemical# and#
mechanical#stimuli.#Both#subtypes#were#found#to#be#chemosensitive.#Pulmonary#
C=fibre#activation#occurred#on#injection#of#capsaicin#into#the#right#atrium#resulting#
in# bradycardia# and# apnoea.# Stimulation# also# occurred# on# exposure# to#
prostaglandins#(Coleridge#and#Coleridge#1977M#Coleridge#et#al.#1978).##Mechano=
sensitivity# was# also# a# feature# of# pulmonary# C=fibres# but# this# occurs# on# large#
inflations# of# the# chest# onlyM# they# are# quiescent# during# normal# respiration.#


















some# nerve# endings# that# could# not# be# located# may# have# been# within# the#
vasculature# itself# and# the# presence# of# systemic=pulmonary# anastamoses#may#
have#also#affected#the#interpretation#(Santambrogio#1982).#
#
Unmyelinated# fibres# identified# in# the# epithelium# of# mammals,# (believed# to# be#
synonymous# with# bronchial# C=fibres)# contain# neuropeptides,# in# particular#
calcitonin#gene=related#peptide# (CGRP)#and# the# tachykinins#substance#P# (SP)#
and#neurokinin#A#(NKA).#Retrograde#tracing#studies#in#guinea#pigs#have#identified#
that# neuropeptide=containing# fibres# usually# arise# from# the# jugular# ganglion,#
whereas# non=neuropeptide# containing# fibres# arise# from# the# nodose# ganglia#
(Undem# et# al.,# 2004).# Following# synthesis# of# the# neuropeptides# they# are#
transported#from#the#jugular#ganglion#and#stored#in#the#peripheral#fibre#endings#
until#C=fibres#are#stimulated# in# the#respiratory# tract#which#triggers# their# release#
(Lundberg# and# Saria# 1987M# Barnes# 1990).# The# stimulation# of# these# nerves#
endings#can#result# in#neuropeptide#release#by#a# local#axon#reflex,#or#a#central#







muscle# cells,# cholinergic# ganglia,# inflammatory# cells# and#mucous# cells,# which#












epithelium,# lamina# propria,# bronchial# and# vascular# smooth# muscle# and#
surrounding#glands#in#human#airways#(Lundberg#et#al.#1984M#Ollerenshaw#et#al.#
1991M# Lamb# and# Sparrow# 2002).# Other# studies# failed# to# identify# these# fibres#
however#(Laitinen#et#al.#1983M#Howarth#et#al.#1991),#which#may#be#as#a#result#of#
tissue#fixation#delays#or#as#others#have#found#may#be#related#to#age#and#smoking#
(Hislop# et# al.# 1990M# Lamb# and# Sparrow# 2002).# A# more# recent# study# using#
immunohistochemistry# in# smoking# and# non=smoking# COPD# patients# identified#
that# non=smoking# COPD# patients# had# increased# SP# immunoreactivity# in# the#










their# physiological# role#after# this# stage# is# less#well# understood# (Barnes#1990).#
Electron#microscopy#has#shown#that#neuroepithelial#body#cells#contain#numerous#


















Firstly,# neural# tissue# has# been# found# to# be# in# close# association#with# the# cells#
implicated# in# the# pathogenesis# of# pulmonary# fibrosis,# such# as# epithelial# cells,#
fibroblasts#and#the#extra=cellular#matrix#(Brewster#et#al.#1990M#Lamb#and#Sparrow#
2002).#It#is#suggested#that#it#is#the#interactions#between#these#components#that#






through# the# release# of# tachykinins# such# as# substance# P,# which# can# induce#
capillary# leak# and# a# subsequent# cascade# of# inflammatory# responses# (Barnes#
2001).# Increased# numbers# of# SP# containing# nerves# have# been# found# in# the#
airways#of#asthmatic#patients#(Ollerenshaw#et#al.#1991)#as#well#as#elevated#levels#
of#SP#in#sputum#and#BAL#fluid#of#asthmatic#patients#when#compared#to#controls#
(Nieber# et# al.# 1992M# Tomaki# et# al.# 1995).# There# is# also# evidence# that#SP#and#









been# found# to# regulate# inflammatory# processes# (Hoyle# 2003)# and# have# a#
fibrogenic#effect#on#skin#and#lung#fibroblasts#(Micera#et#al.#2001).#They#can#be#
expressed#and#released#by#a#variety#of#cell#types#within#the#respiratory#epithelium.#
Studies# have# shown# that# amongst# other# actions# neurotrophins# modulate# the#





















Cough# reflexes# play# an# essential# role# in# protecting# the# respiratory# tract,#
maintaining#airway# function#and#gaseous#exchange.#Our#understanding#of# the#
neurophysiology# of# cough# is# largely# derived# from# animal# studies# with# limited#
human#data.#
#
The# vagal# afferents# are# responsible# for# initiating# the# cough# reflex.#Cough# can#
originate#from#any#of#the#structures#that#are#innervated#by#the#vagus,#including#
the#lungs,#external#ear,#oesophagus#and#abdominal#organs#(Widdicombe#1995).#
Sensory# information# from# these# structures# is# carried# in# the# vagus# to# the#
brainstem,#where#the#afferent#fibres#synapse#with#second#order#neurones#in#the#


















RARs# have# long# been# thought# of# as# the# principal# afferent# nerve# fibres# that#
mediate#cough#in#the#airways#(Widdicombe#1995).#The#location#of#RARs#in#the#
extra=pulmonary#airways#(larynx,#trachea#and#large#bronchi)#and#their#activation#
by# chemical# and#mechanical# stimulation# provided# the# initial# evidence# for# their#
involvement# (Widdicombe# 1954c).# Vagal# cooling# studies# in# cats# and# dogs#
provided# further# evidence#as# cough#was# inhibited#on# cooling# the# vagus#nerve#
70#
#
which# inhibits#conduction# through#RARs#whilst#allowing#C=fibres# to# function#as#
normal#(Widdicombe#1954cM#Anderson#et#al.#1990).#Some#authors#questioned#the#
primary# role# of# RARs# in# cough# mediation,# however# due# to# the# following#
observations# to# the#contrary.#Firstly,# it#was#noted# that#whilst#RARs#had#shown#
activation#to#a#number#of#chemical#stimuli#such#as#tachykinins,#methacholine,#and#
forced# inspiration# or# expiration# against# a# closed# glottis,# stimulation#with# these#
mediators#often#failed#to#result#in#cough#(Widdicombe#1954cM#Canning#et#al.#2004M#
Canning#2006)#Secondly,#animal# studies#had#shown# that#RARs#can#be#active#




colleagues# proposing# the# fibres# originating# from# the# large# and# upper# airways#
being#a# fibre# type#distinct# from#RARs# (Canning#et# al.# 2004).#The#presence#of#
intrapulmonary#RARs#has#not#been#questioned,#however#rather# than#playing#a#





The# role# of# C=fibres# in# mediating# cough# has# also# been# the# subject# of# much#
controversy#and#still# remains#unclear.#Their#activation#by#capsaicin,#bradykinin#






inhibited# by# desensitisation# with# capsaicin# whereas# it# failed# to# inhibit# cough#
induced#by#mechanical# irritation#believed#at#that#time#to#be#mediated#by#RARs#
(Forsberg# et# al.# 1988).# This# is# believed# to# occur# as# a# result# of# peptide# (SP)#
depletion# from# the# sensory# nerve# endings.# The# capsaicin# antagonist,#










fibres,# but# either# results# in# inhibition# of# the# neural# pathway# or# the# conscious#
perception# of# airways# irritation# (Canning# 2006).# This# latter# hypothesis# is#
supported# by# the# ability# of# normal# volunteers# to# suppress# cough# induced# by#
capsaicin#inhalation,#which#suggests#that#C=fibre#mediated#cough#may#not#strictly#
be# a# reflex# response# (Hutchings# et# al.# 1993M# Mazzone# 2005).# It# has# been#





subtypes# with# neuropeptide# containing# fibres# that# originate# from# the# jugular#
ganglion# which# initiate# coughing,# whereas# the# nodose# originating# non=
neuropeptide#containing#fibres#inhibit#cough#(Canning#et#al.#2004M#Canning#and#










RARs# represent# the# principal# afferent# fibre# regulating# cough,# or# the# ‘cough#















which# are# not# features# of# the# guinea# pig# cough# receptor,# are# present# in# the#







In# summary,# current# evidence# suggests# that# C=fibre# afferents# and# extra=
pulmonary#Aδ=fibres,#(known#in#guinea#pigs#as#cough#receptors)#have#key#roles#
in# cough# regulation.# These# two# fibre# types# may# represent# different# neuronal#
pathways,#with#the#extra=pulmonary#Aδ=fibres#facilitating#a#basic#defensive#cough#
reflex#and# the#C=fibres# facilitating#cough#which# is#under#a#degree#of# voluntary#
control# (Canning# and# Chou# 2009M# Woodcock# et# al.# 2010).# It# is# likely,# that#
interactions#exist#between#the#two#pathways#and#the#pathways#of#other#afferent#



















As# previously# described,# unmyelinated# C=fibres# have# been# found# to# contain#




shown# to#have#neuromodulatory#and# immunodulatory# influences#and#a# role# in#
inflammation#of#the#lung#(Daniele#et#al.#1992).#A#peripheral#sensory#autonomic#
reflex#is#also#present,#by#which#the#neuropeptides#released#mediate#cholinergic#







inactivates# tachykinins# that# have# been# released# following# nerve# stimulation#
(Sekizawa#et#al.#1996).#As#well#as#the#role#of#tachykinins#and#in#particular#SP#in#
‘neurogenic# inflammation’# as# described#previously,# its# role# in# cough#has#been#
extensively# investigated.# Animal# studies# have# shown# that# there# is# a# dose=




SP#and#capsaicin,# (Hope=Gill#et#al.#2003)#and#elevated#SP# levels# in#BAL# fluid#











result# in# local# changes# in# bronchial# smooth# muscle# contraction# and# mucous#












(PGE=2)# are# produced# and# secreted# in# the# lungs# in# response# to# a# variety# of#
inflammatory#conditions.#They#are#all# known#endogenous#C=fibre#stimulants# in#
animals# (Kaufman#et# al.# 1980)#and#have#been#demonstrated# to# induce#cough#
directly# in# normal# and# asthmatic# patients# (Choudry# et# al.# 1989).# Patients#with#
chronic# cough# have# also# been# shown# to# have# increased# levels# of# these# pro=
inflammatory#mediators#in#induced#sputum#(Birring#et#al.#2004).#
#
These#mediators#are#also#believed# to# increase# the#sensitivity#of#afferent#nerve#
fibres# (Carr# 2004).# They# sensitise# protein# channels# on# afferent#C=fibres# via#G#
protein=coupled# receptor#mechanisms,#as#discussed# in#more#detail# in# the#next#
section#(Maher#et#al.#2011).#Studies#confirming#this#heightened#sensitivity#have#
been#conducted# in#animals#and#humans.#For#example,#bradykinin#reduced#the#
electrical# threshold#of#citric#acid# induced#cough# in#guinea#pigs#(Mazzone#et#al.#
2005),# and# in#man# capsaicin# induced# cough#was# found# to# be# increased# after#
inhalation# of# PGE2# (Choudry# et# al.# 1989).# Bradykinin=induced# sensitisation# of#
airway# nerves# has# in# particular# been# implicated# in# the# pathogenesis# of#







As#outlined# in# the#section#on#pulmonary# innervation,#neurotrophins#are#growth#






binding# to# high=affinity# tyrosine# kinase# (TK)# receptors# on# vagal# sensory# nerve#





Neurotrophins# have# been# implicated# in# the# sensitisation# of# afferent# fibres# and#








sensitisation’# is# thought# to# be# a# consequence# of# this# functional# change# as#
increased#neuropeptide#release#can#augment#synaptic#transmission#in#the#central#
nervous#systemM#this#possibly#results#in#a#tachykinin#mediated#response#from#a#
mechanical# stimulus# (Kollarik# and# Undem# 2003).# This# phenomenon# is# widely#
appreciated#in#the#peripheral#sensory#system#and#can#result#in#chronic#pain.#The#
process# of# ‘central# sensitisation’# has# also# been# implicated# in# the# association#
between# cough# and# gastro=oesophageal# (GOR)# refluxM# it# is# postulated# that#
afferent# oesophageal# and# airway# fibres#may# converge# in# the# central# nervous#
system,#and#an#altered#sensitivity#in#one#pathway#could#alter#the#CNS#response#





patients# with# idiopathic# chronic# cough# has# been# identified,# which# may# be#
associated#with#increased#neurotrophin#levels#(Niimi#et#al.#2003M#Niimi#and#Chung#
2004).# Also# as# described# previously,# neurotrophins# have# also# been# shown# to#











of# patients# with# chronic# cough# with# control# subjects.# Although# the# density# of#
CRGP=#immunoreactive#nerves#present#in#the#epithelium#were#significantly#higher#
in# chronic# cough# patients# there#was# not# a# significant# difference# in# total# nerve#
density#visualised#using#a#general#nerve#marker,#protein#gene#product=#9.5#(PGP=#
















in# membrane# depolarisation# in# the# peripheral# terminals# of# the# afferent# fibres#
(Kollarik# and# Undem# 2006).# There# are# a# number# of# identified# ion# channels,#
however# the# key# ones# involved# in# this# process# include:# Transient# Receptor#
Potential# channels,# sodium# channels# of# the# Degenerin/Epithelial# (ENaC=
Deg)#family,#5=Hydroxytryptamine3#receptors,#Purinergic#2X#receptors,#Bradykinin#
B2#receptors,#Adenosine#receptors#and#Nicotinic#acetylcholine#receptors#(Kollarik#






receptor# potential# (TRP)# family# of# ion# channels# that# modulate# sensory# and#
inflammatory#information.#This#proteinacious#ion#channel,#which#is#expressed#on#
the#neuronal#plasma#membrane,# is# the#molecular# target#of#capsaicin#action#on#
sensory#neurons,#which#is#why#it#is#otherwise#known#as#the#capsaicin#receptor.#
TRPV=1#was#first#cloned#and#characterised#in#1997#(Caterina#et#al.#1997),#and#its#
role# in# cough# was# confirmed# in# guinea# pigs# using# capsazepine,# a# capsaicin#
antagonist#(Lalloo#et#al.#1995).#
#




TRPV=1# immunoreactive# non=neuropeptide# containing# fibres# were# also#




within# the# lower# airways# down# to# the# alveolar# level# (Watanabe# et# al.# 2005).#







tetramers# to# form# cation=permeable# pores.# On# adequate# stimulation# the# non=
selective# cation# channel,# (which# is# highly# permeable# to# calcium),# opens# and#
allows# ions# to# flow# through# initiating# a# nerve# impulse# and# the# subsequent#
response#from#the#neuronal#pathway#(Caterina#et#al.#1997M#Clapham#2003).#Being#
a#polymodal#receptor,#as#well#as#being#activated#by#capsaicin#it#is#also#activated#
by# numerous# exogenous# and# endogenous# agonists,# heat# (>42# ºc)# and#
extracellular#protons#(pH#<#6.0)#(Surowy#et#al.#2010).#This#activation#either#occurs#
directly#or#indirectly#via#G#protein=coupled#receptors#on#the#cell#membrane#which#








































































As# well# as# desensitisation# occurring# in# TRPV=1# channels,# as# shown# by# the#
inhibition#of#cough#with#capsaicin#pre=treatment# in#experiments# in#guinea#pigs,#
sensitisation# can# also# occur# (Surowy# et# al.# 2010).# TRPV=1# sensitisation# of#
peripheral#nociceptors#is#believed#to#be#responsible#for#hyperalgesia#in#chronic#
pain,#and#there#is#growing#evidence#for#its#role#in#cough#(Nilius#et#al.#2007M#Adcock#
2009).# Endogenous# pro=inflammatory# mediators# including# bradykinin,#
prostaglandins# (PGE2)# and# NGF# (which# are# released# during# inflammatory#
processes)# can# sensitise# TRPV=1#which# reduces# the# activation# threshold# and#































































































profiles,# which# was# positively# correlated# with# capsaicin# tussive# response#
(Groneberg#et#al.#2004a).#A#second#study#failed#to#show#a#difference#in#neuronal#




the#expression#of#TRPV(1# ion#channels# in#airway#afferent#neurons# that#do#not#
normally#express#them#(Zhang#et#al.#2008).#The#neurotrophin,#nerve#growth#factor#

















et# al.# 1999).# TRPA(1# is# insensitive# to# capsaicin,# but# instead# binds# allyl#
isothiocyanate#and#allicin#found#in#mustard#oil#and#garlic#respectively,#and#is#also#
activated#by#cold#air#and#a#number#of#environmental# irritants#such#as#acrolein,#
and# other# electrophilic# compounds# that# are# present# in# air# pollution,# vehicle#
exhaust#fumes,#and#cigarette#smoke#(Taylor(Clark#et#al.#2009).##
#
Animal# studies# have# shown# that# TRPA(1# is# co(expressed# with# TRPV(1# on#
neuropeptide#C(fibre#afferents,#and#stimulation#of#the#TRPA(1#channel#results#in#
C(fibre#activation#(Nassenstein#et#al.#2008Q#Taylor(Clark#et#al.#2008Q#Taylor(Clark#
et# al.# 2009).# Cultured# human# pulmonary# cells# and# preliminary#
immunohistochemical# studies# on# human# bronchial# biopsy# samples# have# also#
confirmed#the#expression#of#TRPA(1#in#the#epithelium,#smooth#muscle#bundles#
and#nerve#tissue#(Anand#et#al.#2008Q#Faruqi#et#al.#2011a).#The#role#of#TRPA(1#in#















Given# the# co(localisation#of# the# two#TRP#channels# it# is# likely# that# cooperation#
occurs,# however# this# is# currently# unproven.# TRPA(1# has# been# found# to# be#
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the# molecular# role# and# interactions# of# the# TRPV(1# and# TRPA(1# channels,#
uncertainty# remains# with# regards# the# regulation# of# TRPV(1# and# TRPA(1#
transcription# in#humans.#Transcription# is#a#process# in#which# the#enzyme#RNA#








strand# to# initiate# transcription# (Lodish# 2000).# Analysis# of# genomic# data# with#
algorithms#such#as#DECODE:#DECipherment#Of#DNA#Elements# (Qiagen,#UK)#
which# explore# genome# databases! have# predicted# a# number# of# regions# within#
TRPV(1#and#TRPA(1#that#are#anticipated#to#bind#a#wide#range#of# transcription#
factors# and# therefore# act# as# promoter# regions.#Biological# validation# of# several#
TRPV(1# transcription# factors# including# specificity# protein# 1# (Sp1)# # (Chu# et# al.#
2011),#Runt#related#transcription#factor#(RUNX1)#and#CCAAT/enhancer(binding#
protein#beta# (C/EBP#β)# (Ugarte#et# al.# 2013)#has#been#achieved# in# the#murine#
model,# however# the# promoter# sequences# are# not# well# understood# in# humans#
(Park#et#al.#2007).#Human#promoter#sequences#for#TRPA(1#have#been#identified#













(de# la# Rosa# et# al.# 2000).# This# is# a# relatively# newly# recognised# group# of# ion#
channelsQ#the#first#ASIC#was#cloned#in#1997#(Waldmann#et#al.#1997).#Six#different#
proteins# arising# from# four# genes# have#been# cloned# to# date,#ASIC1a,#ASIC1b,#
ASIC2a#and#ASIC2b,#ASIC3#and#ASIC4# (Wemmie#et#al.#2006).#Four#of# these#
subunits# form# functional# homomultimeric# channels,# with# # homomeric# and#
heteromeric# ASICs# having# distinct# pH# sensitivity,# ion# selectivity,# and# channel#
kinetics# (Hesselager#et# al.# 2004).#ASICs#are#expressed#widely# throughout# the#








It#was#noted# that#an#extracellular#pH#of#7.0# resulted# in#only#a# transient# inward#
current#which#the#current(voltage#curve#indicated#was#predominantly#as#a#result#
of# sodium# influx,#whereas#a#pH#of# less# than#6.5# resulted# in#a# slow,# sustained#
inward# current.# The# transient# inward# current# was# subsequently# inhibited# by#
amiloride#in#a#dose#dependent#manner,#confirming#the#role#of#the#ASIC,#while#the#



















Firstly,# Protease(activated# 2# receptors# (PAR2)# have# been# shown# to# increase#
sensitivity.#These#are#G(protein#coupled#receptors#that#are#found#throughout#the#
airways.# Endogenous# inflammatory# mediators# and# exogenous# proteases#
modulate#their#activity#and#PAR2#has#been#shown#to#be#elevated#in#a#variety#of#




play# a# role# in# inflammatory# lung# disease,# as# a# result# of# simultaneous# PAR2#
activation#and#tissue#acidification#(Gu#and#Lee#2011).#
#
The# response# of# acid(sensing# channels# in# response# to# temperature#was# also#
recently#studied#and#showed#the#sensitivity#of#ASIC#channels#to#acid#was#inhibited#








that#knowledge#of# their# location#and#mode#of#activation#remains# limited.#Better#
knowledge#of#the#cough#mechanisms#at#the#molecular#level#gives#us#insight#into#













morbidity# (Morice# 2008).# Global# prevalence# has# been# estimated# at# 9.6%,#
however#there#is#significant#heterogeneity#in#the#CC#definitions#used,#which#may#
affect#the#validity#of#this#estimate#(Song#et#al.#2015).#There#are#many#potential#
causes# of# CC# with# the# most# common# thought# to# be# as# a# result# of#
asthma/eosinophilic# bronchitis,# rhino(sinusitis# and#GORD# (Morice# et# al.# 2004Q#




that# in# this# sub(set# of# patients# with# CC# of# unknown# cause# (idiopathic# chronic#
cough),# that# CC# is# a# distinct# clinical# syndrome# characterised# by# neuronal#
hypersensitivity,# which# has# been# termed# cough# hypersensitivity# syndrome#
(Morice# 2010Q# Chung# 2011Q# Escamilla# and# Roche# 2014).# It# has# also# been#
demonstrated#that#patients#with#chronic#cough#are#less#able#to#suppress#cough#
during#a#capsaicin#cough#challenge#than#normal#volunteers#(Young#et#al.#2009).#
The# epidemiological# and# resultant# economic# burden# of# CC# has# resulted# in#
increased#research#in#an#attempt#to#identify#therapeutic#targets#(Irwin#et#al.#2006aQ#
Morice#et#al.#2007Q#Song#et#al.#2015),#and#as#a#consequence#has#also#aided#our#





Chronic# cough# is# a# common# symptom# described# in# patients# with# Idiopathic#
Pulmonary#Fibrosis#and#impairs#quality#of#life#(French#et#al.#1998Q#Ryerson#et#al.#
2011).#Recent#studies#using#24#hour#cough#monitoring#were#able#to#quantify#the#
extent# of# this# debilitating# symptom,# and# illustrated# the# need# for# a# better#
understanding#of#the#pathogenesis#to#allow#therapeutic#developments#(Key#et#al.#
2010).# It# has# always# seemed# inconsistent# that# cough# should# be# a# prominent#
symptom#of#a#disease#that#affects#the#peripheral#lung#parenchyma,#whereas#the#
afferent# fibres# believed# to# be# associated# with# cough# are# concentrated# in# the#
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Gastro(oesophageal# reflux# (GOR)#and# the#micro(aspiration#of#gastric# contents#
into#the#airways#has#been#implicated#in#the#pathogenesis#of#cough#in#IPF#as#well#
as#the#disease#itself#as#already#discussed#in#chapter#1.#Patients#with#IPF#have#
been# found# to# have# a# high# prevalence# of# GOR# on# 24# hour# oesophageal# pH#
monitoring#and#manometry,#and#are#often#asymptomatic#(Tobin#et#al.#1998Q#Patti#
et# al.# 2005Q# Raghu# et# al.# 2006aQ# Noth# et# al.# 2012).# There# are# two# theories#
regarding#how#GOR#can# result# in#cough.#One# involves# the#micro(aspiration#of#
gastric# fluid# into# the# lungs# resulting# in# sensory# afferent# activation# and#
inflammation.#The#second#as#discussed#previously#involves#afferent#oesophageal#
and# airway# fibres# converging# in# the# central# nervous# system,# with# altered#
sensitivity# in# one# pathway# altering# the# CNS# response# to# the# other# i.e.#
physiological#distal# reflux# in# the#distal#oesophagus#resulting# in#cough,#which# is#
supported#by#studies#in#which#acid#instilled#into#the#distal#oesophagus#triggered#
cough#in#patients#with#asthma#and#chronic#cough#(Wu#et#al.#2002Q#Javorkova#et#











Interestingly,# recent# studies# using# a# combination# of# oesophageal# pH# and#
impedance# monitoringQ# which# is# able# to# characterise# all# reflux# episodes#





and# post# a# period# of# acid# suppression#which# demonstrated# that# proton# pump#
inhibitors#(PPI)#had#no#effect#on#cough#symptoms#despite# the#abolition#of#acid#
reflux# and# yet# resulted# in# an# increase# in# non(acid# reflux# (Kilduff# et# al.# 2014).#
Proton#pump#inhibitors#have#not#found#to#be#completely#effective#in#the#treatment#
of# chronic# cough# and# interestingly# in# these# patients# both# acid# and# non(acidic#
reflux#result#in#a#heightened#cough#reflex#sensitivity#(Chang#et#al.#2006Q#Qiu#et#al.#
2011).# An# in# vitro# study# also# provides# supporting# evidence,# with# GOR# from#




increased# into# the# other# components# of# gastric# refluxate# such# as# pepsin,#
pancreatic#enzymes#and#bile#salts.##
#





with# chronic# cough# (Grabowski#et# al.# 2011).# It# is# recognised#however# that# the#












by# other# co(morbidities,# and# these# often# confound# the# study# of# cough# in# IPF#
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#
(Harrison# 2013).# Common# co(morbidities# include# rhino(sinusitis,# obstructive#





obstructive# sleep# apnoea# (OSA)# has# been# increasingly# recognised# as# a# co(
morbidity#associated#with#IPF#(Schiza#et#al.#2015).#One#single#centre#study#of#50#
patients#with#IPF#and#an#average#BMI#of#32.2,#reported#a#diagnosis#of#OSA#in#
88%# of# patients,# with# 34# (68%)# patients# having# moderate(to(severe# OSA#
(Lancaster# et# al.# 2009).# Interestingly,# OSA# has# been# associated# with# chronic#
cough,#with#a#reported#incidence#of#33%#in#one#study#of#108#patients#referred#for#
OSA# assessment# (Chan# et# al.# 2010).# As# there# is# clinical# and# epidemiological#
evidence# supporting# an# association# between# OSA# and# GOR# (Demeter# et# al.#
2005Q#Jung#et#al.#2010),#it#was#proposed#that#IPF,#GOR#and#OSA#were#linked#and#
resulted# in# a# ‘vicious# triad’# that# provoked# cough# (Harrison# 2013).# A# study#





The# current# evidence# suggests# that# although# co(morbidities# are# an# important#
consideration#when#performing#an#assessment#of#a#patient#with#IPF#and#cough#









on# interstitial# cells# of# patients# with# IPF# using# immuno(histochemical# analysis#




number# of# mechanisms.# In# addition,# patients# with# IPF# have# a# direct# cough#
response#to#capsaicin#and#increased#levels#of#the#neuropeptide#substance#P#in#
BAL# fluid,# which# supports# the# possibility# of# a# functional# and# or# structural# up(
regulation#of# sensory# afferents# in# IPF# (Takeyama#et# al.# 1996Q#Hope(Gill# et# al.#








Another#possible#mechanism#for# the#cause#of#cough# in# IPF# is# that#mechanical#
distortion#of#small#airways#due#to#peribronchiolar#fibrosis#may#result#in#enhanced#
stimulation#of#the#peripheral#RARs#or#destruction#of#the#peripheral#inhibitory#nerve#
fibres.# A# study# which# provides# evidence# for# this# theory# compared# the# cough#
response#of#mechanical#stimulation#to#the#posterior#chest#wall#in#patients#with#IPF#
and# controls.# Enhanced# cough# reflex# sensitivity# to# chest# wall# vibration# was#
observed#in#IPF#patients#but#was#not#seen#in#control#subjects#(Jones#et#al.#2011).#
However,#the#lack#of#clear#correlation#between#capsaicin#cough#sensitivity#with#
measures# of# lung# function# (Doherty# et# al.# 2000aQ# Hope(Gill# et# al.# 2003)# and#
objective#measures#of#cough#severity#with#lung#function#testing#(Key#et#al.#2010)##







with# IPF# has# demonstrated# that# the# presence# of# the# MUC5B# minor# T# allele#
polymorphism#was#significantly#correlated#with#cough#severity#as#measured#by#
LCQ#(Scholand#et#al.#2014).#The#MUC5B#gene#has#a#role# in#the#production#of#
airway#mucus# and# as# described# in# chapter# 1# has# also# been# implicated# in# the#




could# accumulate# and# trigger# a# non(productive# or# productive# cough.# They#
suggest# that# their# findings#are#corroborated#by# the#demonstration#of# increased#
MUC5B# mucin# expressing# cells# on# Immunofluorescence# in# the# distal# airway#
epithelium#of#IPF#patients#compared#with#controls#(Seibold#et#al.#2011).#The#main#
limitation#of#the#study#by#Scholand#et#al#was#that#they#did#not#control#for#co(morbid#
diseases# in# IPF# that# can# also# cause# cough# and# therefore# the# results# need#







early# study# found# that# the# presence# of# cough# in# patients# with# CFA# had# no#
influence# over# survival# (Turner(Warwick# et# al.# 1980),# however# a# study# of# 242#
patients#with# IPF#has#shown#cough# to#be#an# independent#predictor#of#disease#




























Thalidomide! Thalidomide# is# an# immune(modulating# anti(fibrotic#
agent#which#has#been#investigated#as#a#treatment#for#
cough# in# IPF.# 23# patients#with# IPF#were# randomly#
assigned# to# thalidomide# or# placebo# in# a# 24# week,#
double#blind#crossover# trial.#The#primary#end#point#
was# an# improvement# in# the# Cough# Quality# of# life#
Questionnaire,#which#was#significantly#higher#in#the#
thalidomide# group,# and# there# was# also# an#
improvement#seen#on#VAS#score.#However#adverse#






over# a# 10# week# period,# gabapentin# was# found# to#
result#in#a#reduced#cough#severity#and#an#improved#
quality# of# life# related# to# their# cough.# There# was##
however#a#relatively#high#rate#of#withdrawal#from#the#
study# (10)# (Ryan# et# al.# 2012).# The# basis# for# the#
therapeutic# action# of# this# agent# is# based# on# the#
theory#of# cough# in# IPF#being#as#a# result#of# central#
sensitisation.#




their# cough# as# assessed# by# LCQ# (Lutherer# et# al.#
2011).##




of# assessment# (Azuma#et# al.# 2011).#A# subsequent#
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#
retrospective# study# from# the# Netherlands# has# also#
shown#a#reduction#in#cough#score#in#a#group#of#11/19#
patients#with# IPF(associated# cough# (Wijsenbeek#et#
al.# 2015).# A# prospective,# multi(centre# cohort# study#
assessing# the# effect# of# pirfenidone# on# cough# in#
patients#with#IPF#(Cough(IPF)#is#currently#recruiting.#
Nintedanib! Little# is# known# about# the# effect# of# nintedanib# on#
cough# in# IPF.#One# small# study# reported# subjective#
improvement# in# cough# in# 12# out# of# 36# patients#
(Bonella#et#al.#2013).#
Azithromycin! Azithromycin# is# a# macrolide# antibiotic# with#
immunomodulatory#effects.#It#is#believed#that#it#might#
improve#cough#related#quality#of#life#in#patients#with#
IPF.# A# randomised,# placebo(controlled# trial# is#
currently#recruiting#in#Berne,#Switzerland.#
Morphine! In# a# study# of# 27# patients# with# chronic# cough# in# a#
randomised# double(blind# placebo(controlled# study,#
there# was# a# significant# improvement# in# cough#
severity#measured#using#LCQ#in#the#patients#taking#
5(#10#mg#morphine#twice#daily.#However#there#was#
no# significant# change# in# cough# reflex# sensitivity# to#




AF5219! AF(219# is# an# oral# antagonist# of# the# P2X3# cough#
receptor#which#is#believed#to#be#involved#in#mediating#
cough# reflex# sensitivity.# A# recent# phase# 2,#


















interpreted# with# caution,# as# cough# is# a# symptom# that# can# be# considerably#
influenced#by#the#placebo#effect#(Van#den#Bergh#et#al.#2012).#A#number#of#these#
medications# also# have# significant# side# effects# and# cannot# to# be# tolerated.# At#




This# review# highlights# the# progress# made# over# recent# years# regarding# the#
neurophysiology#of#cough#and#the#pathogenesis#of#cough#in#IPF,#however#gaps#
in# our# knowledge# clearly# exist# and# at# present# treatments# for# this# troublesome#
symptom#remain#limited.#Further#investigation#into#the#pathogenesis#of#cough#in#











is# accumulating# evidence# to# suggest# that# this# is# as# a# consequence# of# altered#
cough#neurophysiology.#Given#the#evidence#in#patients#with#chronic#cough#(who#
also# have# an# augmented# cough# reflex)# supporting# a# link# between# cough#






As# cough# reflex# sensitivity# is# increased# to# capsaicin,# I# hypothesise# that# the#











1.# Does# airway# TRPV(1# and# TRPA(1# receptor# protein# expression# differ#
between#subjects#with# IPF#and# those#with# idiopathic#chronic#cough#and#
controls?#



















In#order# to#assess#TRPV(1#and#TRPA(1#expression# in# IPF#patients,# bronchial#
biopsies#from#IPF#patients#were#compared#with#patients#with#idiopathic#chronic#






















radiologist#with#a#specialist# interest# in#pulmonary#disease#at# the#MDT#meeting#
also#allowed#co(existing#emphysema#to#be#excluded#in#this#group#of#IPF#patients.#
Bronchoalveolar#lavage#was#performed#on#all#IPF#patients#as#part#of#their#routine#
clinical# investigation# in# order# to# exclude# alternative# diagnoses# such# as#
hypersensitivity#pneumonitis#as#shown#in#appendix#1.##
#
Idiopathic# chronic# cough#patients#were# identified# as# those#patients#with# a# ># 3#




cough#had#at# least#a#1(month#trial#of# treatment#with#a#proton#pump#inhibitor# in#
order#to#eliminate#GOR#reflux#as#a#cause#of#cough.#Co(existent#bronchial#hyper(
reactivity# was# excluded# following# thorough# clinical# assessment,# in# addition#
reversibility# testing# or# methacholine# challenge# testing# were# performed# where#
there#was#clinical#uncertainty.##
‘Normal’# control# patients# were# identified# as# patients# who# did# not# complain# of#






patients# were# also# recruited# into# a# pilot# group# to# allow# for# experimental#
optimisationQ#these#patients#were#not#subject#to#the#exclusion#criteria.#
#
A# target#sample#size#of#40#patients# (20# IPF,#10#chronic#cough#and#10#control#
subjects)# was# selected# on# the# basis# that# comparison# between# two# or# three#
groups,#each#of#size#ten,#is#powered#to#detect#a#difference#of#1.1#to#1.25#standard#







Research# and# Development# Committee# and# the# Local# Research# Ethics#




















































Flexible# fibre(optic# bronchoscopy# was# performed# in# all# recruited# patients# for#
diagnostic# purposes# using# an# Olympus# Lucera# CV(260# scope,# according# to#
established#guidelines#(Honeybourne#et#al.#2001).# Intravenous#midazolam#was#
given#pre(procedure#and#topical#anaesthesia#of#the#upper#airways#and#larynx#was#



































































RNA# concentration# was# quantified# using# a# ND(1000# spectrophotometer#
(NanoDrop#products,#Wilmington,#DE,#USA.)#1.5#µl#RNA#was# tested#against#a#
blank#of#RNAse/DNAse#free#water.#For#patient#samples,#which#yielded#less#than#








of# ≥# 1.8# was# achieved# in# all# samples# accept# 4# of# the# samples# with# reduced#



























































Double6stranded$ DNA$ is$ heated$
which$causes$the$helix$to$open$into$
two$single6stranded$DNA$templates.$
SYBR$ green$ I$ dye$ molecules$ are$
unbound$ in$ the$ presence$ of$









Taq$ DNA$ polymerase$ attaches$ to$
the$ primed$ template$ and$ begins$
synthesis.$SYBR$green$I$binds$to$all$
newly$ synthesised$ DS6DNA,$ which$

















The$ intensity$ of$ fluorescence$
generated$ by$ SYBR$ green$ I$ above$

























nonSintron$ spanning,$ therefore$ alternative$ primers$ were$ designed$ using$
Primer3Plus$Version:$2.3.3$software$package$(Untergasser$et$al.$2012).$ Intron$
spanning$primers,$are$primers$which$anneal$to$separate$exons,$this$type$of$primer$











$ HPRT$ GAPDH/$TRPAS1$ TBP/$TRPVS1$
Reagent$ Volume$(µl)$per$reaction$
MgCl2$(25$µM)$ 1.6$ 2$ 2.4$
Forward$primer$(5$µM)$ 2$ 2$ 2$
Reverse$primer$(5$µM)$ 2$ 2$ 2$
FS$Mix*$ 2$ 2$ 2$
H20$ 10.4$ 10$ 9.6$
cDNA$template$ 2$ 2$ 2$


















(°C)( 95$ 95$ 55/58/60*$ 72$
Temperature(
(°C)( 65<95$
Time((s)( 600$ 10$ 5$ 5$ Rate(change((°C/s)( 0.1$













The$ use$ of$ reference$ genes$ is$ essential$ to$ improve$ reliability$ of$ qPCR$ data.$
Reference$genes$are$used$ to$normalise$ the$data?$ the$ ratio$of$gene$of$ interest$





however$ the$expression$of$ reference$genes$ can$ vary$ considerably$ in$different$






published$ geNorm$ studies$ that$ rank$ the$ stability$ of$ reference$ genes$ in$ lung$
epithelial$ cells$ and/or$ tissue.$This$ literature$ review$ failed$ to$ identify$ a$ geNorm$
study$for$IPF$or$idiopathic$chronic$cough$patients,$so$the$reference$genes$were$
chosen$based$on$their$stability$in$the$A549$pulmonary$epithelial$cell$line.$This$cell$
line$ was$ chosen$ to$ act$ as$ the$ positive$ control$ in$ all$ experiments$ as$ it$ is$ a$
commonly$ studied$ lung$ cell$ line.$ Also,$ since$ patient$ samples$ were$ precious,$
conditions$ were$ optimised$ using$ material$ derived$ from$ human$ cells$ lines$ of$
pulmonary$origin.$BEASU2B$bronchial$epithelial$cells$as$well$as$the$A549$alveolar$
epithelial$cells$were$used$for$ this$purpose.$Further$details$on$ the$cell$ lines$are$
outlined$in$section$2.2.1.$
$
In$ an$ attempt$ to$ improve$ the$ reliability$ of$ the$ reference$ genes$ in$ the$ patient$




in$ the$ tissue$ or$ cell$ line$ studied.$ Hellemans$ et$ al$ have$ shown$ that$ mean$



































































A# limitation#of#using#SYBR#Green# I# is# that# it# is# less#specific# than#probeNbased#
technologies,#such# that#any#doubleNstranded#DNA#(dsDNA)# #may#be#detected,#
including#primer#dimers#and#nonNspecific#amplification#(Ririe#et#al.#1997).#A#postN
amplification# melting# curve# plots# the# change# in# fluorescence# observed# when#
dsDNA# dissociates,# into# singleNstranded# DNA# (ssDNA)# and# is# achieved# by#
increasing#the#temperature#over#the#melting#temperature#of#the#amplicon.#When#
the#melting#temperature#is#reached#there#is#a#sudden#decrease#in#fluorescence,#














Bands# corresponding# to# each# PCR# product# were# extracted# from# the# gel# and#
purified# using# the# QIAquick# Gel# Extraction# Kit# (QIAGEN,# Hilden,# Germany),#
following# the# manufacturer’s# instructions.# Purified# DNA# concentration# was#
measured# using# a# NanoPhotometer# (IMPLEN,# Germany)# and# products# with#






data# library# using# the# BLAST# software# provided# by# the# National# Centre# for#
Biotechnology# Information# (NCBI).# The# nucleotide# sequence# obtained# using#
TRPVN1#primers#was#most#closely#related#to#the#transcripts#1N4#of#Homo$sapiens#
transient# receptor# potential# cation# channel,# subfamily# V,# member# 1# (TRPVN
1)# (accession# numbers:# NM_080704.3,# NM_018727.5,# NM_080706.3,#
NM_080705.3,# 98%# identity).# The# PCRNamplified# fragment# using# the# TRPAN1#
primers#was#most#closely#related# to#Homo$sapiens# transient# receptor#potential#









































































this#study.#To# limit#potential#errors# in# the#calculated#expression#ratios# that#can#
result# from#variation# in# the#amplification#efficiencies#of# individual#assays,#PCR#
efficiency#was#calculated#for#each#primer#set#using#the#calibration#curve#method.#
This#uses#linear#regression#to#produce#a#formula#for#the#relationship#between#the#
resultant#Ct# (cycle# threshold)# values#of# serially# diluted# input# cDNA,#where# the#
cycle# threshold# is# defined# as# the# number# of# PCR# cycles# required# for# the#












inhibitors#within# the# sample# are# also# diluted#which#may# lead# to#more# efficient#





The# calibration# curves# are# shown# in# Figure# 20# and# a# summary# of# the# PCR#





Primer* PCR#efficiency* PCR#efficiency#(%)* Slope#(m)* Intercept#(c)*
TRPVN1* 1.9063* 90.63* N3.5691* 22.3078*
TRPAN1* 1.9447* 94.47* N3.4619* 24.5287*
HPRT* 1.8731* 87.31* N3.6688* 19.9564*
TBP* 1.8127* 81.27* N3.8712* 23.8255*





































primers.# Each# colour# and# point# shape# represents# an# experimental# repeat.#











































































































































The# dilution# series# and# experimental# data# obtained# from# the# Lightcycler®# 2.0#
(Roche# Diagnostics# Ltd,# West# Sussex,# UK)# was# uploaded# onto# qBasePlus#










‘target# specific# amplification# efficiency’# and# normalisation# strategy# was# set# to#
‘reference#targets’#as#previously#described.#Normalisation#was#evaluated#within#
qBasePlus#by# two#quality# control#measuresU# ‘the# coefficient# of# variation#of# the#
normalised#reference#gene#expression#levels#and#the#geNorm#stability#MNvalue#
(Hellemans# et# al.# 2007).’# Removing# GAPDH# from# the# analysis# improved# the#

























































specimens# were# evaluated# by# myself# and# Dr# Allen# Gibbs,# an# experienced#
histopathologist#with#a#special#interest#in#pulmonary#pathology.#All#reviewers#were#
unaware# of# the# grouping# of# each# subject.# A# multiNheaded# Olympus# BX51#
microscope#was#used.#Pilot#samples#were#used#to#decide#upon#the#criteria#used#
for# assessment.# Examined# parameters# included# the# presence# and# degree# of#
basement# membrane# thickening,# chronic# inflammation# and# mucous# cell#
hyperplasia# as# shown# in# table# 7.# Basement# membranes# were# considered#













# No! No! # No!
# Yes:#1N#Mild! Yes! ####Yes:#Mild!
########## 2N#Moderate! ! #### Moderate!
########## 3N#Severe#! ! # #Severe#!
$





















Figure!22! Representative! H! &! E! images! demonstrating!
basement!membrane!thickening!






























































Immunohistochemistry# was# performed# using# the# Dako# Flex™# Envision# +# kit,#
product# code# K8002# (Dako,# Denmark).# The# sections# were# first# floated# onto#
‘Flex’™#slides#and#dried#for#1#hour#at#60#°c.#The#slides#were#then#placed#into#a#
Dako# preNtreatment# module# chamber# containing# target# retrieval# solution# (pH#
dependent#on#antibody,#see#Table#8).#The#slides#were#heated#within#the#module#
to#97°c#for#20#minutes#and#then#cooled#to#65°c#before#being#placed#immediately#
into# Dako# wash# buffer# for# 5# minutes.# This# step# incorporates# deNwaxing,#
rehydration#and#heat#induced#epitope#retrieval.#The#slides#were#loaded#onto#the#
Dako#Autostainer#Link#48#™#staining#machine.#A#Dako#horseradish#peroxidase#
(HRP)# block# was# added# for# 5# minutes# to# block# any# endogenous# peroxidase#
present#and#then#washed#twice#in#buffer#solution.#The#primary#antibody#was#then#
added#(see#table#8#for#concentrations)#for#20#minutes#followed#by#a#buffer#wash.#
A# second# 20# minute# incubation# with# Dako# EnVision™# FLEX# /HRP# polymer#
allowed# detection# of# the# primary# antibody.# Two# 5#minute# incubations# in#Dako#
substrate#working#solution#followed#by#a#wash#allowed#visualisation#of#the#antigen#
antibody# complex# by# the# enzymatic# reduction# of# 3,# 3Ndiaminobenzine#
tetrahydrochloride# (DAB).# A# final# 5Nminute# incubation# with# Dako# Flex#
Haematoxylin#was#performed#for#counterstaining.#Slides#were#then#removed#from#
the#staining#machine#and#dehydrated#(through#a#series#of#graded#alcohol#baths)#
then# ‘cleared’# (through# a# series# of# Xylene# baths)# and# mounted# using# a# DPX#




within# the# laboratory,#experience#of#staff# in#using# the# tissue# type#and#previous#
130#
#























Antibody# Concentration# Retrieval#solution#pH# Product#code# Reference#



















Any$ discrepancies$ in$ the$ results$ were$ resolved$ by$ consensus$ following$
reassessment$of$the$slide$by$both$investigators.$Images$were$viewed$an$Olympus$













pixels$ within$ the$ area$ of$ interest$ on$ each$ slide$ allowing$ the$ area$ of$ specific$
immunostaining$ and$ the$ total$ area$ to$ be$measured$and$ therefore$ the$ positive$



























Independent$ statistical$ advice$was$ sought$ and$ obtained$ from$Dr$Mark$Kelson$
from$the$Research$Design$and$Conduct$Service$(RDCS)$run$by$Cardiff$University.$













All$ qPCR$data$was$Log10$ transformed$ to$ensure$ it$ fitted$a$normal$distribution.$
Average$ gene$ expression$ between$ the$ groups$ was$ assessed$ using$ ANOVA,$
however$linear$logistic$regression$was$also$used$to$account$for$the$other$variables$




Binary$ logistic$ regression$was$ originally$ chosen$ to$ analyse$whether$ PGPK9.5,$





test$ and$ MannKWhitney$ U$ test$ were$ used$ to$ compare$ parametric$ and$ nonK























Human$adenocarcinoma,$alveolar$ epithelial$ (A549)$ cells$ and$normal$ bronchial$
epithelial$ (BEASK2B)$cells$were$obtained$ from$ the$European$Collection$of$Cell$
Cultures$ (ECACC).$ The$ A549$ cell$ line$ was$ originally$ derived$ from$ a$ 58$ year$
Caucasian$male$with$adenocarcinoma$of$the$lung,$whereas$the$BEASK2B$cell$line$




A549$ cells$were$ grown$ in$Dulbecco's$Modified$Eagle's$medium$ (DMEM)$ (Life$
technologies,$ Paisly,$ UK)$ and$ BEASK2B$ in$ F12K$ medium$ (Life$ technologies,$
Paisly,$UK)$containing$10%$foetal$bovine$serum.$Both$media$were$supplemented$




Cell$ lines$ were$ subKcultured$ when$ subKconfluent$ (70K80%)$ under$ aseptic$














isolated$ from$ cultured$ cells$ (up$ to$ 6$ x$ 106)$ using$ TRIzol®$ (Life$ technologies,$
Paisley,$UK).$Quantification$was$performed$using$a$NDK1000$spectrophotometer$
(NanoDrop$products,$Wilmington,$DE,$USA).$Using$2.5$µg$of$RNA,$ firstKstrand$








buffer$ stained$ with$ ethidium$ bromide.$ Gels$ were$ visualised$ and$ photographs$













TRPV>1! NM_080704.3! Fwd:$ GCAAGAACATCTGCAAGCTGC$$$$$$$$$$$$$$$$$$Rv:$$$ GCTGACAGAGCACTGGTGTTC$! 531!
(Yu$et$al.$
2012)!





















Up$to$1.5$ litres$of$gastric$ juice$ is$secreted$per$day$and$this$ is$essential$ for$ the$
initiation$of$digestion$of$food<stuff$that$enters$the$stomach.$Gastric$juice$contains$
acid,$pepsin,$bacteria$and$occasionally$duodenal$factors$such$as$bile$acids$and$
pancreatic$ enzymes.$ Reflux$ of$ gastric$ juice$ through$ the$ lower$ oesophageal$
sphincter$ into$ the$ oesophagus$ is$ a$ normal$ physiological$ event.$ The$ complex$
mixture$of$these$components$results$in$a$liquid$or$gas,$which$may$be$an$alkaline,$
acidic$or$neutral$pH.$The$pH$of$the$refluxate$is$an$important$factor$as$it$influences$
the$ cellular$ toxicity,$ enzymatic$ activity$ and$ constitution$ of$ the$ separate$
components.$$
$














chief$ and$ mucous$ cells,$ and$ has$ been$ implicated$ as$ a$ cause$ of$
oesophageal$ damage$ during$ GOR.$ Various$ concentrations$ of$ pepsin$
(Sigma,$UK)$were$made$by$dissolution$in$sterile$growth$media$(0.5mg/ml<$
10mg/ml).$ Preliminary$ experiments$ were$ carried$ out$ using$ pepsin$
concentrations$based$on$those$previously$studied$(Bathoorn$et$al.$2011S$
Johnston$et$al.$2012).$The$activity$and$stability$of$pepsin$is$affected$by$the$
pH$ of$ its$ solution$ (Piper$ and$ Fenton$ 1965S$ Bardhan$ et$ al.$ 2012),$ with$
increased$peptic$activity$at$lower$pH$and$inactivation$of$the$enzyme$at$pH$
>$ 8.$ The$ pepsin$ concentration$ (1mg/ml),$ chosen$based$on$ the$ findings$
141$
$









without$GOR$disease$ (Kauer$et$ al.$ 1997)$ In$humans$bile$ acids$exist$ in$
several$ forms:$ as$ free$ (unconjugated)$ bile$ acids,$ bile$ acids$ bound$ to$
sodium$or$potassium$salts,$or$bile$salts$that$are$conjugated$with$glycine,$




a$ process$ of$ bacterial$ overgrowth,$ and$ then$ have$ an$ increased$ role$
(Hofmann$ and$ Small$ 1967S$ Pearson$ and$ Parikh$ 2011).$ In$ this$ study$
unconjugated$ chenodeoxycholic$ acid$ (CD)$ and$ conjugated$
glycochenodeoxycholic$acid$(GD)$(Sigma,$UK)$were$used.$Animal$studies$
have$ demonstrated$ that$ conjugated$ bile$ salts$ are$ injurious$ to$ the$













constituents$ was$ decided$ following$ a$ series$ of$ preliminary$ experiments$ as$
142$
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! !    
$
CD/GD:$50µM<$
500µM$ ! !    
$
Ethanol$carrier$
0.5<5%$ ! !    
$
pH:$2,$4,$6,$8$ ! ! ! ! ! $
Pepsin$1mg/ml$$
$pH$2<8$$ ! ! ! ! ! 
$




















Pepsin:$1mg/ml$  ! !   $
CD/GD:$50µM$  ! !   $
Ethanol$carrier$
0.5%$  ! !   
$
pH:$6,$8$  ! !   $
pH:$4,$6,$8$     ! $
Pepsin$1mg/ml$
pH6<8$  ! !   
$
Pepsin$1mg/ml$$
pH$6$     ! 
$


















Pepsin:$1mg/ml$  !    $
CD/GD:$50µM$  !    $
Ethanol$carrier$
0.5%$  !    
$
pH:$6,$8$  !    $
pH:$4,$6,$8$     ! $
Pepsin$1mg/ml$
pH6<8$  !    
$
Pepsin$1mg/ml$$





















and$ allowed$ to$ adhere$ overnight.$ The$ cells$ were$ treated$ with$ various$




precisely$with$ a$ stopwatch$ and$ following$ treatment$ each$well$was$ rinsed$with$










the$ cells$ biologically$ when$ examined$ microscopically$ but$ the$ difference$ in$
absorbance$failed$to$reach$statistical$significance,$therefore$the$cells$were$clearly$
damaged$or$distressed$but$remained$metabolically$active$(Figure$42$in$section$















This$ 96$ well$ plate$ shows$ the$ colour$ change$ seen$ in$ this$ cell$












cells$ needed$ for$ this$ experiment,$ cells$ were$ seeded$ in$ 6$ well$ plates$ at$ the$
observed$ optimum$ density$ of$ 100,000$ cells$ per$ well$ and$ allowed$ to$ adhere$
overnight.$The$cells$were$exposed$to$the$gastric$constituents$for$1$hour$per$day$
for$3$days$(bile$salts$and$pepsin)$or$for$5$minutes$for$one$day$(acidified$media$



















the$ cells$ rinsed$with$ Phosphate<buffered$ saline$ (PBS)$ prior$ to$ the$ addition$ of$
Trypsin$ EDTA$ 0.25%$ (Life$ technologies,$ Paisley,$ UK).$ Cells$ were$ pelleted,$
washed$in$cold$PBS$twice,$and$re<suspended$in$binding$buffers$containing$the$
Annexin<V$Cy5$(Biovision,$Cambridge,$UK)$and$Propidium$iodide$(Sigma<Aldrich$
Company$Ltd,$Dorset,$UK)$stains$according$ to$ the$manufacturer’s$ instructions.$





Each$ run$ contained$ a$ negative$ (untreated)$ control$ and$ positive$ control.$ Initial$
experiments$ using$ rotenone$ (Sigma<Aldrich$ Company$ Ltd,$ Dorset,$ UK)$ and$
serum<free$ media$ as$ a$ positive$ control$ failed$ to$ provide$ adequate$ results$
therefore$cisplatin$100$µM$(Accord$healthcare$limited,$UK)$for$48$hours$was$used$
(Liu$et$al.$2013).$All$ samples$were$ run$ in$duplicate$and$experiments$ repeated$
three$times.$Data$was$analysed$using$FCS$express$version$4$(De$Novo$software).$













A549!Negative!Control! !!!!A549!Positive!Control! !!!!!!!!!!!!BEAS72B!Negative!Control! !!!!!!!BEAS72B!Positive!Control!
!



















to$ gain$ as$ much$ information$ as$ possible$ regarding$ the$ expression$ of$ TRP$
receptors$in$response$to$the$acid$and$nonDacidic$components$of$gastric$refluxate.$
$























included$ in$each$ run.$The$carrier$control$was$ included$ to$ensure$any$potential$









Following$ completion$ of$ the$ cell$ exposures$ as$ detailed$ above,$ 1ml$ of$ TRIzol$










total$RNA$quality$ is$by$assigning$a$RNA$ integrity$number$ (RIN).$The$RIN$ is$a$
numbering$system$from$1$to$10$which$reflects$the$degree$of$RNA$degradationd$1$
being$degraded$and$10$being$most$intact$(Biomedical$Genomics$2007).$1$µl$of$
seven$ random$ samples$ were$ assessed$ by$ Mrs$ Amanda$ Gilkes$ (Research$
Assistant,$ Institute$ of$ Cancer$ and$ Genetics,$ Cardiff$ University)$ using$ a$ 2100$











Diagnostics$ Ltd,$ West$ Sussex,$ UK)$ using$ the$ same$ primer$ templates$ and$
conditions$as$previously$described.$cDNA$from$the$RT$reaction$was$diluted$1$/$4$
(0.125$µg$cDNA)$for$cell$line$samples.$All$samples$were$run$in$duplicate$with$a$







2007).$Each$experiment$ (N=3)$was$analysed$using$ this$software$separately$ in$
order$ to$ enable$ the$ normalisation$ strategy$ to$ be$ set$ to$ the$ control$ (untreated$
sample).$ The$ amplification$ efficiency$ was$ calculated$ using$ ‘target$ specific$
amplification$ efficiency’.$ Normalisation$ was$ performed$ using$ TBP,$ HPRT$ and$






intervals$ following$ their$exposure$ to$ the$gastric$constituents.$The$supernatants$
were$stored$at$a$temperature$of$D80°C$before$use$in$the$assay.$
$
ILD8$was$measured$ in$ the$A549$ cells$ only.$Nunc$MaxiSorp®$microliter$ 96Dwell$





of$ a$ recombinant$ human$ ILD8$ standard$ (R$ &$D$ Systems,$ Abingdon,$ UK)$ was$
prepared$using$TBSDT$(TrisDbuffered$saline$0.1%,$BSA$0.05%$and$Tween$20$at$
pH$7.3)$with$a$ final$ standard$curve$ range$of$31.25D$2000$pg/ml.$100$µl$of$ the$
samples$and$standards$were$then$added$to$the$wells$in$duplicate$and$incubated$






conjugated$streptavidin$ (Life$ technologies,$paisley,$UK)$and$a$20$minute$ room$
temperature$incubation.$After$a$further$three$washes$in$wash$buffer,$100$µl$of$the$
chromogenic$substrate$Tetramethylbenzidine$(TMB)$was$added$and$ incubated$


















ILD6$ and$ ILD8$ in$ each$ sample$ was$ determined$ by$ interpolating$ from$ the$







the$ preliminary$ experiments,$ANOVA$was$used$ to$ compare$ the$means$of$ the$






however$ hypothesis$ generating$ studies$ often$ lower$ the$ requirements$ of$ the$
ANOVA,$accepting$the$violations$but$interpreting$the$results$with$caution$(Bowker$
2007).$As$ the$aim$of$ these$experiments$was$ to$exclude$concentrations$where$
there$ was$ a$ biologically$ or$ statistically$ significant$ change$ in$ absorbance$ from$
control,$ parametric$ testing$ was$ deemed$ more$ sensitive$ despite$ violating$ the$
assumption$of$normality.$All$qPCR$data$was$Log10$transformed$to$ensure$it$fitted$
a$normal$distribution.$ShapiroDWilk$and$Levene’s$test$were$performed$to$confirm$




































Five$ patients$ were$ recruited$ into$ a$ pilot$ group$ to$ allow$ for$ experimental$
optimisationd$these$patients$were$not$included$in$the$final$analysis.$$
$

































































































































































trial$ of$ proton$ pump$ inhibitor$ prior$ to$ bronchoscopy,$ no$ patients$ had$ active$
































Gene$ expression$ is$ presented$ as$ relative$ quantity$ and$ represents$ a$ fold$
difference$ in$ gene$ expression$ compared$ to$ the$ calibrator$ sample$ (ratio),$
normalised$against$ the$chosen$reference$genes$HPRT$and$TBP$as$detailed$ in$
section$ 2.1.8.$ The$ choice$ of$ calibrator$ sample$ does$ not$ influence$ the$ relative$
quantity,$ as$ although$ the$ average$ quantity$may$ be$ different$ the$ fold$ changes$




presented$ on$ a$ Log10$ scale$ in$ figures$ 32b$ and$ 33b$ as$ this$ allows$ easier$


























































































































































































































failed$ to$ reach$statistical$significance$ (β$=$0.137,$95%$CI$=$ D0.025,$0.299,$p$=$





with$caution$as$ the$study$was$not$designed$ to$ investigate$TRPVD1$expression$







‘normal’$ controls,$ with$ a$ 1.939$ fold$ increase$ in$ the$ IPF$ group$ and$ 1.300$ fold$






































and$ gene$ expression$ was$ carried$ out$ on$ the$ chronic$ cough$ and$ IPF$ groups$
combined$and$on$each$study$group$individually$as$presented$in$Table$13.$There$




expression$ and$ both$ measures$ of$ cough$ severity$ when$ the$ groups$ were$
combined.$On$separation$of$ the$groups$ the$correlation$between$TRPVD1$gene$
expression$and$LCQ$failed$to$reach$significance.$However,$a$significant$negative$








































































All$ patients$ gave$ consent$ to$ have$ up$ to$ ten$ biopsies$ taken$ at$ the$ time$ of$
bronchoscopy,$ however$ the$ priority$ during$ the$ procedure$ was$ to$ obtain$ the$
samples$required$for$clinical$care.$$Samples$for$research$purposes$were$therefore$
only$ obtained$ once$ the$ usual$ diagnostic$ procedure$ had$ been$ completed$ and$
providing$ the$ patient$ tolerated$ the$ procedure$ well.$ Samples$ were$ placed$ into$
RNAlaterTM!(Ambion,$Paisley,$UK)$as$a$priority$ therefore$ if$ the$patient$ failed$to$
tolerate$the$procedure$a$matching$sample$was$not$obtained$for$histopathological$
and$ immunohistochemical$ analysis.$ This$ occurred$ in$ 3$ out$ of$ 35$ patients.$ A$





basement$ membrane$ thickening$ and$ mucous$ cell$ hyperplasia$ as$ outlined$ in$
Chapter$2.1.9.$
$
No$ patients$ had$ evidence$ of$ acute$ inflammation$ on$H$&$E$ staining,$ however,$
surprisingly$ the$majority$ of$ patients$ had$ some$degree$of$ chronic$ inflammation$
composed$of$ a$ lymphocytic$ infiltration.$ There$was$also$ evidence$of$ basement$
membrane$ thickening,$mucous$ cell$ hyperplasia$ and$ areas$ of$ focal$ squamous$
metaplasia$in$all$three$groups$as$shown$in$Table$14.$There$were$no$significant$



















No! 1$(17%)! 2$(14%)! 1$(14%)!
0.528!
Mild$! 2$(33%)! 8$(57%)! 3$(43%)!
Moderate$! 2$(33%)! 4$(29%)! 3$(43%)!
Severe$! 1$(17%)! 0! 0!
Basement$membrane$thickening!
No! 4$(67%)! 9$(64%)! 5$(71%)!
0.999!
Yes! 2$(33%)! 5$(36%)! 2$(29%)!
Epithelium$abnormality!
Focal$squamous$metaplasia! 1$(17%)! 4$(29%)! 1$(14%)! 0.845!
























































The$positive$ control$ (appendix$ tissue)$ is$ shown$ in$ panel$A,$
with$ the$ black$ arrows$ denoting$ TRPV*1$ specific$ staining.$
Bronchial$ sections$ incubated$ in$ the$ absence$of$ the$ primary$
antibody$showed$no$staining,$a$representative$image$is$shown$
in$ panel$ B.$ Panel$ C$ shows$ IHC$ staining$ of$ airway$ nerves$






















sections$ incubated$ in$ the$ absence$ of$ the$ primary$ antibody$
showed$no$staining,$a$representative$image$is$shown$in$panel$
B.$ Panel$ C$ shows$ IHC$ staining$ of$ airway$ nerves$ (vertical$




















All$ samples$ had$ positive$ TRPA*1$ airway$ epithelial$ cell$ stainingW$ table$ 15c$
summarises$the$TRPA*1$nerve$profile$and$smooth$muscle$staining.$Compared$to$




























! PGP*9.5! ! ! ! !
! Positive! Negative! ! ! ! !
NC! 4/6$(67%)! 2/6$(33%)! P$value! ! ! !
IPF! 10/14$(71%)! 4/14$(29%)! 0.999! ! ! !






TABLE!15a! Airway!nerve!profile!PGP99.5!staining! ! !
! ! ! ! ! ! !
! TRPV*1! ! ! ! !
! Positive! Negative! ! ! ! !
NC! 3/6$(50%)! 3/6$(50%)! P$value! ! ! !
IPF! 9/14$(64%)! 5/14$(36%)! 0.642! ! ! !




! ! ! ! ! ! !
! TRPA*1! !
! Nerve! ! Smooth$muscle! !
! Positive! Negative! ! Positive! Negative! !
NC! 1/6$(17%)! 5/6$(83%)! P$value! 2/5$(40%)*! 3/5$(60%)*! P$value!
IPF! 9/14$(64%)! 5/14$(36%)! 0.141! 8/14$(57%)! 6/14$(43%)! 0.628!








Following$ the$ manual$ immunohistochemical$ assessment$ digital$ quantification$









statistically$ significant$ difference$ in$ PGP*9.5$ immunostaining$ between$ the$
controls$and$patients$with$IPF$or$CC$(Figure$38).$
$
Median$ TRPV*1$ immunostaining$ was$ 0.124$%$ (0.01*0.29$%)$ in$ IPF$ patients,$
which$ was$ higher$ than$ the$median$ percentage$ seen$ in$ CC$ and$ NC$ patients,$
however$this$this$difference$was$minimal$and$did$not$reach$statistical$significance$
(p$ =$ 0.53)$ as$ shown$ in$ (Figure$ 39).$ The$ difference$ in$ TRPV*1$ IHC$ staining$




































































Quantification$ of$ TRPA*1$ immunostaining$ was$ more$ difficult$ as$ there$ was$
epithelial$cell$and$stromal$cell$specific$staining$within$the$smooth$muscle$as$well$
as$ neuronal$ staining.$ It$ was$ not$ possible$ to$ separate$ the$ two$ for$ analysis,$
therefore$ total$ immunostaining$ was$ measured.$ There$ was$ no$ statistically$
significant$ difference$ in$ median$ TRPA*1$ immunostaining$ as$ demonstrated$ in$
(Figure$40).$The$difference$in$TRPA*1$IHC$staining$between$the$IPF$group$and$
control$ group$ also$ failed$ to$ reach$ statistical$ significance$ when$ gender,$ ex*







































not$ possible$ to$ quantify$ the$ expression$ of$ TRPA*1$ as$ a$ ratio$ of$ the$ PGP*9.5$
expression$ due$ to$ the$ inclusion$ of$ the$ epithelial$ and$ stromal$ cells$ in$ the$
quantification.$In$an$attempt$to$assess$the$differences$more$accurately$a$manual$
semi*quantitative$ analysis$ of$ TRPA*1$ expression$was$ performed$ as$ shown$ in$
(Figures$41a$and$b).$Although$there$was$a$higher$number$of$patients$with$grade$




























There$ was$ evidence$ of$ agreement$ between$ the$ manual$ assessment$ of$ IHC$










Interestingly,$ there$ was$ a$ statistically$ significant$ increase$ in$ TRPV*1$
immunostaining$observed$ in$ IPF$patients$who$did$not$ receive$a$ trial$of$a$PPI.$









As$ there$ were$ only$ 4$ samples$ in$ total$ without$ any$ evidence$ of$ inflammation,$





There$ was$ no$ statistically$ significant$ difference$ in$ the$ expression$ assessed$
manually$ or$ nerve$ density$ analysed$ digitally$ of$ TRPV*1$ and$ the$ degree$ of$
inflammation$present$(p$=$0.44$and$p$=$0.10$respectively).$$
$
There$ was$ no$ significant$ difference$ in$ the$ expression$ of$ TRPA*1$ in$ smooth$




the$ degree$ of$ inflammation$ which$ almost$ reached$ the$ level$ of$ statistical$
significance$(p$=$0.05).$There$was$increased$TRPA*1$nerve$profile$staining$in$the$
presence$of$mild$inflammation$(positive:$10,$negative:$3),$but$decreased$staining$
in$ moderate$ (positive:$ 3,$ negative:$ 6)$ and$ severe$ (positive:$ 0,$ negative:$ 1)$
inflammation.$This$trend$was$only$observed$when$all$samples$were$combined,$
there$ was$ no$ statistical$ difference$ between$ the$ groups$ and$ there$ was$ no$




















$ Positive$ Negative$ P$value$
Median$VAS$ 50$ 50.5$ 0.999$
Mean$LCQ$ 13.2$ 13.7$ 0.759$
$ TRPA*1$(Nerve)$ $
Median$VAS$ 45.3$ 60$ 0.169$
Mean$LCQ$ 13.9$ 12.8$ 0.515$
$ TRPA*1$(Smooth$muscle)$ $
Median$VAS$ 50$ 51.5$ 0.809$
Mean$LCQ$ 13.7$ 13.2$ 0.758$
$ PGP*9.5$(Nerve)$ $
Median$VAS$ 50$ 39$ 0.933$










































7.$ There$ was$ a$ statistically$ significant$ increase$ in$ TRPV*1$ nerve$ density$
observed$in$a$small$cohort$of$IPF$patients$who$did$not$receive$PPI$therapy.$
$























cells$ lines$ showed$evidence$of$ a$ reduction$ in$ the$ percentage$of$metabolically$
active$ cells$ on$ exposure$ to$ higher$ concentrations$ of$ CD,$ GD$ and$ Pepsin$





but$with$ repeated$exposures$over$ 3$ consecutive$ days$ in$ an$attempt$ to$model$
gastric$reflux$in$vivo.$$Table$17$shows$the$average$(N=3)$viability$(measured$using$
absorbance)$ of$ A549$ and$ BEAS*2B$ cells$ calculated$ as$ a$ percentage$ of$ the$
control$sample,$and$the$corresponding$p*value$of$each$test$dose$compared$with$
the$ control$ sample.$ Pepsin$ at$ various$ pHs$ was$ tested$ at$ a$ number$ of$
concentrations,$however$the$1mg/ml$dose$is$displayed.$The$main$finding$was$that$





















A549$ 100.00$ 104.44$ 109.69$ 106.40$ 101.72$ 63.47$
P"value" " 0.99" 0.77" 0.95" 0.99" 0.01$
BEAS*2B$ 100.00$ 106.13$ 105.26$ 112.66$ 101.99$ 61.76$











A549$ 100.00$ 95.02$ 98.23$ 95.17$ 94.41$ 93.93$
P"value" " 0.89" 0.99" 0.73" 0.88" 0.96"
BEAS*2B$ 100.00$ 99.74$ 105.33$ 103.17$ 110.74$ 99.27$















A549$ 100.00$ 112.04$ 108.28$ 105.17$ 96.38$ 93.56$
P"value" " 0.17" 0.51" 0.86" 0.99" 0.94"
BEAS*2B$ 100.00$ 108.42$ 110.05$ 113.05$ 115.40$ 92.34$











A549$ 100.00$ 110.39$ 110.89$ 101.23$ 27.90$ 27.74$
P"value" " 0.94" 0.97" 0.99" 0.01$ 0.01$
BEAS*2B$ 100.00$ 96.70$ 105.95$ 131.26$ 31.56$ 29.99$
P"value" " 0.99" 0.99" 0.53" 0.005$ 0.004$
$ $
$ Control$ H20$carrier$ pH6$ pH4$ pH2$ $
A549$ 100.00$ 97.36$ 108.91$ 40.83$ 20.38$ $
P"value" " 0.69" 0.69" 0.08" 0.03$ $
BEAS*2B$ 100.00$ 101.71$ 94.90$ 26.53$ 26.94$ $












Reducing$ the$ time$ exposure$ to$ 5$ minutes$ for$ 1$ day$ only$ also$ resulted$ in$ a$
reduction$in$viability$by$almost$half$in$both$cell$lines$on$exposure$to$pepsin$at$pH4$
as$ shown$ in$ table$ 18,$ however$ the$ cells$ tolerated$ this$ short$ exposure$ to$ pH4$

























































pH2# pH6# pH4# pH2#
A549# 100.00# 104.67# 110.13# 103.69# 52.48# 42.17# 99.93# 91.75# 81.55#
P"value" " 0.99" 0.97" 0.99" 0.01$ 0.01$ 0.99" 0.90" 0.04$
BEAS.2B# 100.00# 97.33# 101.72# 101.47# 60.81# 52.05# 96.54# 88.12# 68.48#

























































Viable$(%)$ 94.00$ 76.85$ 93.91$ 94.43$ 91.86$ 93.99$
Apoptotic$(%)$ 0.40$ 12.48$ 0.32$ 0.39$ 0.31$ 0.34$
Necrotic$(%)$ 5.60$ 10.70$ 5.77$ 5.18$ 7.83$ 5.67$
BEASY2B$
Viable$(%)$ 95.26$ 31.93$ 95.44$ 95.23$ 93.20$ 93.37$
Apoptotic$(%)$ 1.31$ 12.91$ 1.03$ 0.85$ 0.91$ 1.02$













Viable$(%)$ 95.01$ 84.64$ 91.49$ 90.74$ 95.32$
Apoptotic$(%)$ 0.57$ 4.20$ 0.35$ 0.86$ 0.90$
Necrotic$(%)$ 4.42$ 11.17$ 8.16$ 8.41$ 3.79$
BEASY2B$
Viable$(%)$ 95.91$ 60.40$ 92.44$ 95.97$ 95.98$
Apoptotic$(%)$ 0.94$ 9.89$ 1.02$ 0.81$ 0.89$




























Viable$(%)$ 92.81$ 70.25$ 94.69$ 94.27$ 92.03$ 88.67$
Apoptotic$(%)$ 0.81$ 15.74$ 0.55$ 0.39$ 0.62$ 0.74$
Necrotic$(%)$ 6.41$ 14.01$ 4.76$ 5.34$ 7.37$ 10.60$
BEASY2B$
Viable$(%)$ 91.52$ 34.21$ 94.90$ 92.59$ 94.87$ 93.90$
Apoptotic$(%)$ 1.01$ 16.49$ 0.97$ 1.33$ 0.61$ 0.69$
































Gene$ expression$ is$ presented$ as$ relative$ quantity$ and$ represents$ a$ fold$
difference$ in$gene$expression$ (otherwise$known$as$ the$ ratio)$compared$ to$ the$
calibrator$sample,$normalised$against$the$chosen$reference$genes$HPRT,$TBP$
and$GAPDH$as$detailed$in$chapter$2.$The$mean$relative$quantities$of$each$TRP$
receptor$ from$ three$ independent$ experiments$ in$ both$ cell$ lines$ are$ shown$ in$












oneYhour$exposures$ to$ various$gastric$ refluxate$ constituents$on$3$ consecutive$
days$is$shown$in$Figure$43a$and$43b.$Compared$with$the$control$sample$TRPVY
1$expression$was$increased$in$the$A549$cells$exposed$to$CD,$GD$and$pepsin$but$
reduced$ in$ those$ exposed$ to$ pH6$ and$ pepsin$ at$ pH6,$ whereas$ TRPVY1$
expression$was$ increased$ in$ all$ exposed$BEASY2B$cells.$ Figure$44a$and$44b$
shows$TRPAY1$expression$in$both$cell$ lines.$Again$the$expression$pattern$was$
different$ in$each$cell$ line,$with$TRPAY1$expression$reduced$compared$with$ the$




















FIGURE!43a!and!43b! TRPVQ1! expression! in! A549! and!































































































































































2B! pulmonary! epithelial! cell! lines!

























































































































TRPVY1$and$TRPAY1$expression$ in$A549$cells$ following$exposure$ to$media$at$
pH4,$pH6$and$pepsin$at$pH6$for$5$minutes$on$one$occasion$is$shown$in$Figure$
45a$and$45b.$As$detailed$earlier,$there$was$excess$cell$death$with$repetitive$acidic$





































































FIGURE!45a!and!45b!! TRPVQ1! and! TRPAQ1! expression! in!
A549! epithelial! cells! following! a!















































































































































































$ 24$hours$ 48$hours$ 24$hours*$ 48$hours$
Control$
$ 13.7$ 22.6$ 5.9$ 10.7$
Ethanol$carrier$
$ 16.6$ 38.1$ 11.3$ 11.1$
H20$carrier$
$ 22.0$ 44.2$ 10.4$ 10.1$
CD$
$ 16.4$ 35.5$ 14.3$ 9.7$
GD$
$ 21.8$ 30.8$ 11.6$ 10.7$
Pepsin$
$ 22.5$ 33.9$ 20.8$ 21.8$
Pepsin/pH6$
$ 13.7$ 19.3$ 41.7$ 27.4$
pH6$
$ 9.5$ 21.6$ 30.2$ 28.7$
P"value"

































































1$ expression$ in$A549$ or$BEASY2B$pulmonary$ epithelial$ cell$ lines$when$
exposed$to$the$major$constituents$of$gastric$refluxate$used$in$this$study.$
$
5.$ There$was$no$statistically$significant$change$ in$ ILY6$or$ ILY8$secretion$ in$
either$ pulmonary$ epithelial$ cell$ line$ following$ exposure$ to$ the$ gastric$































The$ rationale$ for$ investigating$ the$ TRP$ receptors$ in$ IPF$ is$ clear$ as$ there$ is$
evidence$for$the$physiological$upYregulation$of$this$pathwayb$IPF$patients$have$a$
greater$cough$reflex$sensitivity$to$inhaled$capsaicin$(Doherty$et$al.$2000ab$HopeY




This$ is$ the$ first$ time$ these$ receptors$ have$been$ studied$ in$ IPF.$Two$previous$
studies$ have$ investigated$ the$ expression$ of$ TRPVY1$ in$ bronchial$ biopsies$ of$
patients$with$chronic$cough,$which$is$one$reason$why$this$group$was$used$as$a$
‘positive’$ control.$ These$ studies$ both$ quantified$TRPVY1$ expression$ at$ protein$
levelb$one$used$IHC$to$identify$positive$or$negative$staining$(Mitchell$et$al.$2005)$
whilst$the$other$used$immunofluorescence$(IF)$and$a$digital$ imaging$system$to$
quantify$ the$ density$ of$ TRPVY1$ and$ PGPY9.5$ positive$ staining$ nerves$ as$ a$
percentage$of$the$epithelial$area$(Groneberg$et$al.$2004a).$The$first$study$failed$



















The$ studies$ by$ Groneberg$ et$ al$ and$ Mitchell$ et$ al$ investigated$ patients$ with$
chronic$ cough$ of$ any$ aetiology$ and$ included$ patients$ with$ asthma,$ GOR,$
rhinosinusitis,$bronchiectasis,$interstitial$lung$disease$and$postYinfective$cough$as$
well$as$chronic$idiopathic$cough$(unexplained$cough)$(Groneberg$et$al.$2004ab$
Mitchell$ et$ al.$ 2005).$Groneberg$ et$ al.$ comment$ that$ there$was$ no$ significant$
difference$in$TRPVY1$or$PGPY9.5$expression$between$the$patients$with$idiopathic$
chronic$cough$(N$=$14)$and$patients$with$chronic$cough$of$known$cause$(N$=15),$
however$ they$ do$ not$ state$whether$ the$ difference$between$ the$ chronic$ cough$
group$ and$ normal$ controls$ would$ remain$ significant$ if$ only$ the$ patients$ with$
idiopathic$chronic$cough$were$included$in$the$analysis$(Groneberg$et$al.$2004a).$$
Mitchell$et$al.$also$fail$to$comment$on$this$(Mitchell$et$al.$2005).$This$difference$in$












Gastroesophageal$ reflux$ (GOR)$ is$ a$ common$ cause$ of$ chronic$ cough$ and$ is$








presence$ of$ symptoms,$ abnormalities$ on$ endoscopy,$ pH$ and$ or$ impedance$
testing$do$not$prove$causality$or$predict$response$to$treatment$with$PPIs$(Ferrari$
et$ al.$ 1995b$ Madanick$ 2013).$ Current$ guidelines$ suggest$ GOR$ cannot$ be$
excluded$by$a$trial$of$treatment$alone$(Irwin$2006),$and$although$performing$24Y
hour$oesophageal$pHY$impedance$monitoring$to$quantify$the$presence$and$nature$
of$ any$GOR$ in$ all$ patients$ in$ this$ study$would$ have$ been$ ideal,$ this$ was$ not$











events$ (Kilduff$ et$ al.$ 2014).$ Although$ this$ could$ be$ considered$ a$ confounding$















CoYexistent$ bronchial$ hyperYreactivity$was$excluded$ following$ thorough$ clinical$
assessment$ (history,$ clinical$ examination$ and$ spirometric$ testing$ or$ full$
pulmonary$ function$ testing)$and$ reversibility$ testing$or$methacholine$challenge$
testing$was$performed$where$ there$was$clinical$uncertainty$ (5/16$ IPF$patients,$
and$4/11$CC$patients).$There$was$also$no$evidence$of$significant$eosinophilia$
seen$ on$ BAL$ or$ biopsy$ samples$ therefore,$ this$ is$ unlikely$ to$ be$ a$ significant$
confounding$factor$in$the$current$study.$The$exclusion$of$coYexisting$emphysema$
by$assessment$of$the$HRCT$scans$in$the$IPF$group$is$also$a$key$strength$in$this$













did$ not$ complain$ of$ cough$ but$ were$ required$ to$ undergo$ bronchoscopy$ for$
evaluation$ of$ a$ nonYairways$ centred$ disorder$ e.g.$ pulmonary$ nodule/$
haemoptysis.$ This$ was$ advantageous$ from$ an$ ethical$ and$ research$ and$
development$funding$perspective,$however$had$a$number$of$disadvantages.$
$$
One$ disadvantage$ is$ that$ the$ control$ group$ in$ this$ study$ made$ recruitment$
challenging.$As$already$discussed$the$‘normal’$controls$were$also$subject$to$the$
exclusion$criteria$outlined$in$table$1.$These$strict$criteria,$in$particular$the$smoking$




and$ control$ group$ (Mitchell$ et$ al.$ 2005).$Cigarette$ smoking$ in$ the$ absence$ of$















performing$ a$ clinical$ examination$ as$ not$ all$ patients$ underwent$ spirometric$ or$
pulmonary$function$testing.$These$patients$were$often$referred$for$bronchoscopy$
and$ for$ consideration$ of$ study$ participation$ via$ the$ rapid$ access$ lung$ cancer$
pathway$ by$ physicians$ not$ directly$ involved$ in$ the$ study.$ The$ presenting$
complaint$and$history$given$by$the$patient$meant$that$in$50%$of$cases$spirometry$
and$pulmonary$function$testing$was$not$deemed$necessary.$In$retrospect$ethical$
approval$should$have$been$obtained$for$ tests$ that$were$not$part$of$ the$routine$
clinical$care$in$this$patient$group,$to$ensure$a$complete$data$set.$Importantly$there$
was$no$significant$difference$ in$TRPVY1$or$TRPAY1$expression$ in$ the$patients$





status$ and$were$ being$ investigated$ for$ possible$ bronchogenic$ carcinoma$ it$ is$
likely$that$a$proportion$of$the$patients$had$chronic$obstructive$airways$disease.$
This$ is$ important$ to$ consider$ as$ a$ recent$ study$ has$ demonstrated$ increased$
TRPVY1$ mRNA$ expression$ in$ lung$ tissue$ samples$ from$ patients$ with$ COPD$






















men$ and$ women$ within$ the$ normal$ control$ or$ chronic$ cough$ group$ and$ no$










1$ expression$ and$ age$ a$ priori.$ Secondly,$ the$ study$ groups$ differed$ in$ ages$
therefore$ the$ assumption$ of$ independence$ of$ the$ coYvariate$ was$ violated,$
however$following$analysis$and$discussion,$an$independent$statistician$advised$




not$ a$ significant$ predictor$ of$ TRPVY1$ protein$ expression,$ which$ implies$ the$
difference$ seen$ at$ a$ genetic$ level$ may$ not$ transfer$ to$ what$ is$ observed$ at$ a$
208$
$
functional$ level.$ However,$ this$ remains$ an$ interesting$ observation$ and$ in$ any$






the$ two$ studies$ investigating$ TRPVY1$ in$ chronic$ cough$ as$ Groneberg$ et$ al$
recruited$45$patients$in$totalb$29$chronic$cough$(14$idiopathic)$and$16$controls,$








cough$groups.$44$patients$were$ recruited$ in$ total,$however$5$of$ these$patients$
were$allYcomers$whose$samples$were$used$to$pilot$the$experimental$work$and$4$













that$ increasing$ the$ control$ group$ size$ to$ 10$ would$ have$ influenced$ the$ study$
outcome,$ however$ a$ total$ larger$ sample$ size$ may$ have$ allowed$ the$ smaller$
differences$ seen$ between$ the$ groups$ of$ interest$ to$ have$ reached$ statistical$
209$
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however$ does$ have$ restrictions.$ The$ key$ limitation$ is$ the$ size$ of$ the$ biopsy$





right$ lung$was$ used$ in$ each$ patient$ as$ the$ carinae$ are$ a$ convenient$ place$ to$
biopsy$and$this$method$of$sampling$also$allowed$for$direct$comparison$between$






TRPAY1$ in$patients$with$ IPF$and$chronic$cough$compared$with$controls$and$ is$











and$ expertise$ were$ the$ main$ reasons$ IHC$ was$ used$ over$ IF$ in$ this$ study.$
However,$IHC$also$has$the$benefits$of$allowing$tissue$morphology$to$be$assessed$











the$ limitations$associated$with$ the$manual$ interpretation$of$ IHCb$ the$criteria$ for$
assessment$ were$ set$ beforehand$ using$ the$ pilot$ samples,$ two$ observers$
reviewed$the$slides$with$any$discrepancies$in$the$results$resolved$by$consensus$







also$ limitations$ to$ this$ methodology.$ In$ particular$ the$ effect$ of$ regional$
heterogeneity$ can$ still$ be$ missed$ (Jensen$ 2013),$ and$ the$ heterogeneity$ of$
samples$ following$ microYsectioning$ is$ likely$ to$ be$ the$ cause$ of$ a$ number$ of$
samples$having$TRPVY1$and$or$TRPAY1$neuronal$positive$staining$but$no$staining$













attempts$ were$ made$ to$ locate$ and$ acquire$ the$ antibodies$ used$ in$ the$
aforementioned$studies,$however$the$TRPVY1$antibody$used$by$Groneberg$et$al$
(GlaxoSmithKline,$ Harlow,$ UK)$ had$ been$ discontinued$ and$ was$ no$ longer$
available,$ therefore$ the$ antibody$ used$ by$Mitchell$ et$ al$ was$ used$ (AB5370P,$
Chemicon,$UK).$Compared$with$control$patients$we$ found$a$slight$ increase$ in$
TRPVY1$staining$in$the$neuronal$tissue$of$IPF$patients,$but$a$reduction$in$patients$
with$ chronic$ cough.$ Like$Mitchell$ et$ al$we$ failed$ to$ demonstrate$ a$ statistically$
significant$ difference$ in$ TRPVY1$ neuronal$ staining,$ however$ in$ contrast,$ like$
Groneberg$et$al$we$did$not$identify$any$smooth$muscle$myocyte$TRPVY1$staining,$
and$ found$ no$ difference$ in$ PGPY9.5$ staining$ between$ the$ chronic$ cough$ and$





in$ the$ study$by$Mitchell$ et$ al.$The$antibody$ concentrations$ for$ our$ study$were$
optimised$ by$ a$ very$ experienced$ biomedical$ scientist,$ and$ no$ smooth$muscle$
staining$ was$ seen$ when$ the$ background$ levels$ of$ staining$ were$ at$ an$




A$ separate$ study$ of$ bronchial$ TRPVY1$ expression$ in$ patients$ with$ asthma$
demonstrated$expression$in$the$bronchial$epithelium$of$patients$with$asthma$and$
controls$(McGarvey$et$al.$2014)$,$which$ is$ in$contrast$ to$this$and$other$studies$
which$have$shown$only$occasional$(<1%)$or$no$epithelial$cell$staining$(Groneberg$
et$al.$2004ab$Mitchell$et$al.$2005)$.$However,$nonYneuronal$TRPVY1$expression$




2007)$ .The$ differences$may$ be$ as$ a$ result$ of$ the$ antibodies$ used,$ which$ are$
known$ to$ be$ difficult$ to$ identify$ and$ optimise$ (personal$ communication$ Dr$ L,$
Sadofsky,$coYauthor$with$Mitchell$et$al$(Mitchell$et$al.$2005)),$the$method$of$tissue$
processing$and$the$clinical$phenotype$of$the$patient$under$investigation,$however$
again$ this$ brings$ into$ question$ the$ reliability$ and$ reproducibility$ of$ studies$
investigating$protein$expression$of$TRP$receptors.$Of$note$the$IHC$in$the$studies$
by$ Mitchell$ et$ al$ and$ McGarvey$ et$ al.$ were$ manually$ assessed,$ whereas$
computerYaided$image$analysis$was$used$by$Groneberg$et$al.$$
$$
In$ contrast$ to$ TRPVY1,$ this$ study$ confirmed$ the$ nonYneuronal$ expression$ of$




with$manual$ or$ computerYaided$ assessment$ of$ immuneYstaining.$ The$ positive$
staining$in$the$bronchial$epithelium$for$TRPAY1$in$all$samples$was$a$particularly$
surprising$finding.$The$role$of$TRPAY1$in$nonYneuronal$tissue$is$unclear,$however$
there$ is$ evidence$ to$ suggest$ that$ nonYneuronal$ TRPAY1$ could$ be$ involved$ in$
triggering$airway$inflammation$(Fernandes$et$al.$2012b$Grace$et$al.$2014).$The$
evidence$for$this$ is$ largely$taken$from$in$vitro$work,$ in$which$nonYneuronal$cell$
lines$ have$ been$ exposed$ to$ smoke$ particulates$ and$ have$ resulted$ in$ cell$
activation$or$interleukin$release$in$a$TRPAY1$dependent$manner$(Mukhopadhyay$
et$al.$2011b$Nassini$et$al.$2012b$Buech$et$al.$2013b$Shapiro$et$al.$2013).$The$nonY




no$ TRPAY1$ nerve$ profile$ staining,$ and$ surprisingly$ more$ patients$ with$ mild$
inflammation$had$positive$staining$but$there$was$less$positive$staining$in$patients$
with$ moderate$ inflammation.$ Given$ the$ evidence$ for$ the$ role$ of$ TRPAY1$ in$ a$
number$of$ inflammatory$conditions$ it$ is$very$ likely$ that$ it$plays$a$ role$but$what$
remains$unclear$ is$whether$TRPAY1$has$a$ role$ in$ initiating$a$proYinflammatory$
process$ as$ seen$ in$ inYvitro$ and$ rodent$ studies$ or$ whether$ the$ inflammatory$











Quantitative$ PCR$ was$ used$ in$ addition$ to$ IHC$ in$ this$ study$ in$ an$ attempt$ to$
improve$ the$sensitivity$and$specificity$of$ the$experiment$given$ the$ limitation$of$








Every$ effort$ was$ made$ to$ follow$ the$ Minimum$ Information$ for$ Publication$ of$
Quantitative$RealYTime$PCR$Experiments$(MIQE)$guidelines$and$the$extensive$
steps$ taken$ to$optimise$ the$qPCR$assays$and$ensure$appropriate$analysis$as$
described$in$section$2.1$is$a$strength$of$this$study$(Bustin$et$al.$2009).$
$







lowYlevel$ transcripts$ (Bustin$ et$ al.$ 2009).$ 260/280$ ratio$ is$ frequently$ used$ to$
assess$RNA$quality$however$the$MIQE$guidelines$recommend$the$use$of$RNA$
gel$electrophoresis$and$the$quantification$of$RNA$integrity$using$a$RNA$integrity$







composition$ of$ bronchial$ tissue$ (Yahaya$ et$ al.$ 2011).$ Yahaya$ and$ colleagues$






reliability$ of$ the$ qPCR$ assay$ as$ it$ controls$ for$ variations$ in$ the$ amplification$
efficiency$(which$can$be$affected$by$differential$RNA$quality),$and$extraction$yield$
































the$study$ (Bustin$et$al.$2009).$Studies$of$TRPVY1$and$TRPAY1$ in$other$ tissue$
types$ have$ shown$ a$ good$ correlation$ between$ gene$ and$ protein$ expression$






the$ inflammatory$ cascade,$ it$ would$ be$ interesting$ to$ investigate$ whether$ the$
expression$ of$ TRP$ receptors$ in$ the$ airway$ correlated$ with$ the$ presence$ or$
absence$of$chronic$ inflammation$ in$bronchial$epithelium.$(Mitchell$et$al.$2005).$





Only$ 24%$ of$ the$ bronchial$ biopsies$ from$ the$ control$ patients$ in$ the$ study$ by$
Mitchell$ et$ al$ had$ evidence$ of$ chronic$ inflammation$ compared$ to$ 83%$ of$ the$
control$patients$in$the$current$study$(Mitchell$et$al.$2005).$Two$of$the$three$NC$
patients$ who$ had$ moderate$ or$ severe$ chronic$ inflammation$ and$ evidence$ of$
mucous$ cell$ hyperplasia$ were$ exYsmokers.$ Studies$ that$ have$ investigated$
bronchial$ biopsy$ inflammation$ in$ smokers$ and$ exYsmokers$ with$ and$ without$













as$ a$ consequence$ are$ more$ likely$ to$ suffer$ tissue$ damageb$ In$ repeated$
procedures$the$procedure$can$result$in$scar$and$a$cellular$inflammatory$response$
may$be$initiated$prior$to$the$sample$being$fixated$(Jeffery$et$al.$2003).$Although$it$





Connell$ et$ al.$ 1995).$ Inflammation$ is$ typically$ graded$ as$ mild,$ moderate$ and$
severe$ and$ as$ with$ all$ of$ the$ morphological$ features$ assessment$ is$ not$
quantitative$and$is$limited$by$subjectivity.$To$quantify$the$degree$of$inflammation$
we$ could$ have$ used$ IHC$ to$ localise$ and$ count$ the$ number$ of$ lymphocytes,$
however$the$priority$in$the$study$was$to$investigate$airway$innervation$with$IHC$
therefore$ the$ samples$ were$ prioritised.$ The$ classification$ of$ normal$ and$ mild$
inflammation$is$therefore$likely$to$vary$between$different$observers$and$between$
studies,$however$the$finding$of$moderate$and$severe$chronic$inflammation$in$our$
NC$patients$ is$ likely$ to$be$a$valid$result.$A$study$ investigating$the$variability$of$
inflammatory$cell$ counts$on$bronchial$biopsies$ in$normal$ subjects$ (nonYatopic,$






lack$ of$ difference$ in$ histological$ morphology$ between$ the$ groups$ and$ again$
highlights$a$limitation$of$the$normal$control$group$used$in$this$study.$
$
Evidence$ of$ chronic$ inflammation$ on$ bronchial$ biopsy$ has$ been$ identified$ in$









the$central$airways,$ the$histopathology$of$endobronchial$biopsies$ in$ IPF$ is$not$
clearly$defined.$Twelve$(86%)$IPF$patients$had$evidence$of$chronic$inflammation$
in$ the$ central$ airways$ and$ although$ 5$ patients$were$ exYsmokers,$ they$ had$ all$
stopped$smoking$for$longer$than$12$months,$had$no$clinical$evidence$of$chronic$
bronchitis$ and$ none$ of$ the$ IPF$ patients$ had$ a$ productive$ cough,$ making$ a$
confounding$diagnosis$unlikely.$Although$chronic$inflammation$was$increased$in$











related$quality$of$ life$ (QOL)$and$a$VAS$which$ is$a$general$measure$of$ cough$

















in$ particular$ were$ higher$ than$ those$ observed$ in$ other$ studies$ investigating$
chronic$cough$patients$ (Decalmer$et$al.$2007b$Faruqi$et$al.$2011b).$ $This$ is$ in$
contrast$ to$ a$ previous$ study$ showing$ no$ statistical$ difference$ in$ the$ objective$
assessment$ of$ cough$ frequency$ using$ an$ ambulatory$ 24$ hour$ cough$monitor$
between$ these$ two$ groups$ of$ patients$ (Key$ et$ al.$ 2010).$ This$ may$ be$ as$ a$





median$ VAS$ in$ men$ was$ 66,$ compared$ to$ 77$ in$ women.$ CC$ is$ known$ to$





idiopathic$ chronic$ cough$was$ studied.$Women$with$ chronic$ cough$ have$ been$
found$to$have$increased$cough$on$24$hour$ambulatory$monitoring$(Kelsall$et$al.$
2009)$ and$ a$ higher$ cough$ reflex$ sensitivity$ in$ response$ to$ inhaled$ capsaicin$
(Fujimura$et$al.$1996).$There$are$conflicting$results$with$regards$to$the$effect$of$
gender$on$cough$ related$quality$of$ life$ (French$et$al.$2004b$Polley$et$al.$2008b$
Kelsall$et$al.$2009)$however,$and$no$study$has$specifically$looked$at$cough$VAS$
and$gender$in$adults,$but$gender$did$not$significantly$affect$the$VAS$cough$score$
in$ children$ with$ chronic$ cough$ (Chang$ et$ al.$ 2011).$ Also,$ although$ a$ study$
investigating$the$capsaicin$evoked$urge$to$cough$in$normal$patients$failed$to$find$
an$ increased$ urge$ rating$ in$ females$ (Mazzone$ et$ al.$ 2007),$ another$ study$
investigating$chronic$cough$in$which$the$majority$(71%)$of$patients$were$women$
identified$a$severe$‘urge$to$cough’$in$response$to$a$variety$of$precipitants$(Hilton$


























of$ airway$ receptors$ do$ not$ reflect$ the$ severity$ of$ cough$ based$ on$ subjective$
measures.$One$might$expect$a$correlation$to$be$seen$at$a$protein$level$however$
as$ a$ previous$ study$ has$ identified$ a$ correlation$ between$ TRPVY1$ protein$
expression$ and$ cough$ reflex$ sensitivity.$ The$ study$ by$ Groneberg$ et$ al$














elderly$ and$ frail.$ In$ this$ context$ it$ is$ not$ unsurprising$ that$ despite$
recommendations$ for$ chronic$ cough$ to$ be$ investigated$ with$ a$ combination$ of$
subjective$and$objective$measures$(Chung$et$al.$2003b$Decalmer$et$al.$2007)$only$
two$ studies$ investigating$ cough$ and$ IPF$ have$ reported$ ambulatory$ cough$
monitoring$(Key$et$al.$2010b$Kilduff$et$al.$2014).$It$is$also$reported$that$in$patients$
with$chronic$cough,$objective$cough$counts$were$significantly$lower$on$repeated$





























severity$perspective.$However$ it$ is$possible$ that$ the$antagonist$used$had$subY
optimal$ pharmacokinetics$ to$ fully$ occupy$ the$ target$ (Bonvini$ et$ al.$ 2015),$ and$
perhaps$more$likely$that$a$number$of$receptors$and$mechanisms$are$involved$in$
the$clinical$symptom$of$cough,$and$that$targeting$a$single$receptor$is$likely$to$be$












gene$ and$ protein$ expression$ in$ neuronal$ and$ nonYneuronal$ cells$ of$ airway$








their$ importance$ clinically$ with$ certainty.$ It$ is$ also$ not$ possible$ to$ draw$ firm$
conclusions$ between$ the$ relationships$ between$ TRP$ receptor$ expression$ and$
cough$severity$measured$using$VAS$and$LCQ.$$
$
It$ is$ important$ to$ consider$ that$ this$ study$ only$ investigated$ the$ expression$ of$
TRPVY1$and$TRPAY1$receptors.$These$receptors$are$two$members$of$the$TRP$
receptor$ family$ which$ has$ 28$ members$ divided$ into$ 6$ subfamilies$ (Clapham$










as$although$ the$central$ airways$are$ known$ to$have$ increased$ innervation$and$





It$ is$also$possible$ that$a$physiological$upYregulation$of$TRP$ receptors$ through$














receptors$ using$ capsaicin$ and$ other$ agonists$ has$ been$ demonstrated$ in$ vitro$
(Akopian$ et$ al.$ 2007)$ and$ has$ been$ used!widely$ in$ chronic$ pain,$ particularly$
neuropathic$pain$(Szallasi$and$Blumberg$1999b$Sawynok$2005).$A$recent$study$







The$evidence$ for$ inflammation$ in$ the$central$airways,$heightened$cough$ reflex$
sensitivity$and$the$presence$of$neurotrophins$in$the$sputum$of$IPF$patients$also$
support$the$sensitisation$of$the$TRP$receptors$in$this$group.$It$is$possible$that$the$
nonYneuronal$ and$ neuronal$ functions$ of$ TRP$ receptors$ play$ different$ but$























2013b$Shapiro$ et$ al.$ 2013)$ in$ pulmonary$ epithelial$ cell$ lines.$ The$ presence$ of$
these$ receptors$ in$ nonYneuronal$ pulmonary$ cells$ has$ been$ implicated$ in$
modulating$airway$inflammatory$responses$in$health$and$disease,$however$their$
exact$ role$ remains$ unclear$ (Gardner$ 2006).$ The$ study$ also$ confirms$ the$






















the$ individual$ constituents$ of$ gastric$ refluxate$ was$ not$ associated$ with$ a$
statistically$significant$increase$in$gene$expression$of$TRPVY1$or$TRPAY1.$$
$
The$ initial$ concentrations$ of$ the$ gastric$ reflux$ constituents$ were$ based$ on$
concentrations$that$were$thought$to$be$clinically$relevant$$and$were$consistent$
with$those$used$previously,$(Nehra$et$al.$1999b$Jaiswal$et$al.$2006b$Perng$et$al.$
2008b$ Bathoorn$ et$ al.$ 2011b$ Johnston$ et$ al.$ 2012)b$ however,$ it$ is$ difficult$ to$
ascertain$the$clinical$relevance$of$these$concentrations$given$the$variable$degree$
of$ reflux$ and$ composition$ of$ gastric$ refluxate$ in$ each$ individual$ (Gotley$ et$ al.$





2013).$For$example,$ the$ final$concentration$of$pepsin$used$ in$ this$experiment$
was$1mg/ml$because$the$concentration$of$pepsin$in$human$gastric$fluid$ranges$




acute$exacerbation$has$ found$ the$ levels$ to$be$much$ lower$ than$ this$however,$
with$the$maximum$level$in$the$study$reaching$only$92$ng/mlY1$(Lee$et$al.$2012).$










become$ inactive$at$pH$≥$4$and$denatured$above$pH$≥$5.5,$however$ it$ is$now$
appreciated$ that$ pepsin$ does$ not$ become$ completely$ inactivated$ until$ pH$ >8$$
(Piper$and$Fenton$1965b$Bardhan$et$al.$2012).$$Pepsin$has$been$shown$to$be$
toxic$ to$ the$ respiratory$ epithelium,$ with$ the$ inflammatory$ effect$ being$ pH$
dependent$and$a$greater$effect$at$lower$pH$(Bathoorn$et$al.$2011).$It$has$also$
been$ shown$ to$ be$ have$ toxic$ cellular$ effects$ at$ neutral$ pH$ in$ cultured$
hypopharyngeal$cells$however,$which$provides$support$for$the$role$of$nonYacid$
reflux$ in$ the$ pathogenesis$ of$ various$ conditions$ (Johnston$ et$ al.$ 2009).$
Unfortunately$as$seen$in$previous$experiments$investigating$the$cytotoxic$effects$
of$ pepsin,$ (Bathoorn$ et$ al.$ 2011)$ repeated$ and$ prolonged$ exposure$ of$ the$
epithelial$ cells$ to$ an$ acidic$ environment$ resulted$ in$ reduction$ in$ cell$ viability$
particularly$in$the$presence$of$pepsin$therefore$these$cell$lines$are$unsuitable$for$
experiments$assessing$these$conditions.$Rather$than$testing$pepsin$at$a$scale$of$
















(Western$ blot$ analysis)$ and$were$ able$ to$ demonstrate$ that$ this$ was$ an$ ATPY
dependent$process.$The$acidic$exposure$also$resulted$in$an$increased$level$of$
inflammatory$mediators$ and$ cytokines$ supporting$a$ role$ for$TRPVY1$mediated$






with$ no$ reference$ to$ its$ stability$ in$ the$ experimental$ conditions.$ GAPDH$ is$ a$
commonly$used$reference$gene,$however$there$is$great$variation$in$its$expression$




et$ al.$ 2004b$ Bhat$ and$ Bielefeldt$ 2006b$ Guarino$ et$ al.$ 2010),$ with$ increased$
expression$in$patients$with$erosive$and$nonYerosive$gastroesophageal$disease.$
The$ correlation$ between$ TRPV1$ expression$ and$ acid$ exposure$ time$
demonstrated$in$the$in$vitro$study$has$not$been$confirmed$in$vivo$however,$with$
conflicting$results$between$the$studies.$$










A$ key$ strength$ of$ this$ study$ was$ the$ great$ effort$ made$ to$ ensure$ that$ the$





















to$ indirectly$ assess$ TRPVY1$ functionality.$ With$ hindsight$ these$ experiments$
should$ have$ been$ done$ in$ parallel$ to$ the$ cell$ study$ work$ as$ this$ would$ have$





receptor$ agonists$ and$ antagonists$ used$ to$ stimulate$ and$ inhibit$ the$ receptors$
respectively.$Previous$studies$have$demonstrated$calciumYdependent$production$
of$ILY6$in$A549$and$BEASY2B$cell$lines$following$exposure$to$the$TRPVY1$agonist$
capsaicin,$ therefore$ demonstrating$ TRPVY1$ functional$ activation$ (Reilly$ et$ al.$
2003b$Seki$et$al.$2007).$Other$studies$have$also$demonstrated$that$ILY6$and$or$
ILY8$ production$ is$ upregulated$when$ cells$ are$ exposed$ to$HCl$ acid$ (Ma$et$ al.$




used$ the$ assay$ function$ was$ confirmed$ with$ the$ standard$ curves$ and$ the$
experiments$were$carried$out$with$wellYestablished$protocols.$Instead$it$is$likely$
that$ the$ lack$of$ significant$difference$ in$TRP$ receptor$expression$between$ the$
samples$ is$ reflected$ in$ the$ quantity$ of$ ILY6$ and$ ILY8$ released,$ therefore$ the$
interleukin$ studies$ support$ the$ qPCR$ findings.$ However,$ inflammatory$ stimuli$
have$been$shown$ to$upYregulate$TRPVY1$ $ (Mitchell$ et$al.$ 2005),$ therefore$ the$








TRP$receptors$and$an$ inflammatory$response.$ It$ is$however$a$ limitation$ that$a$
positive$control$was$not$used$as$this$would$have$excluded$a$failure$of$the$cells$to$
mount$ an$ inflammatory$ response.$ Interestingly$ a$ study$ that$ investigated$ the$
exposure$of$gastric$juice$to$primary$bronchial$epithelial$cell$lines$(PBECs)$found$
that$ cells$ exposed$ to$ gastric$ juice$ from$ patients$ who$ were$ on$ a$ PPI$ had$ a$
significant$inflammatory$response$as$measured$using$ILY8,$however$there$was$no$
significant$increase$in$ILY8$production$or$correlation$with$dose$when$cells$were$
exposed$ to$ the$ individual$ components:$ pepsin$ and$ bile$ acids$ (Mertens$ et$ al.$
2010).$ In$ retrospect$ to$ensure$ the$clinical$ relevance$of$ the$concentrations,$ the$
experiment$ could$have$been$conducted$using$ filtered$whole$gastric$ juice$ from$
patients$with$IPF$who$had$undergone$24$hour$impedance$and$pH$manometry$and$
controls.$ The$ use$ of$ PPI$ medication$ could$ be$ controlled$ for$ allowing$ the$
investigation$ of$ any$ differences$ in$ acidic$ and$ nonYacidic$ reflux.$ However,$ this$
method$would$have$also$resulted$in$a$number$of$challenges,$namely$in$obtaining$







and$ antagonists,$ the$ calcium$ permeability$ of$ the$ receptor$ or$ its$ voltageYgated$
function$in$patchYclamp$experiments.$However,$a$number$of$studies$have$already$




demonstrating$ that$ the$ receptors$ were$ functional$ would$ have$ added$ to$ the$
































epithelial$ cells$ and$ the$ role$ of$ these$ nonYneuronal$ cells$ remains$ unclear.$ It$ is$
believed$ that$ the$ nonYneuronal$ receptors$ mediate$ inflammation$ through$ the$
release$ of$ inflammatory$ cytokines,$which$ are$ thought$ to$ induce$ upYregulation,$
neurogenic$ inflammation$ and$ modulate$ nociceptive$ signalling.$ The$ conflicting$
results$ with$ regards$ the$ expression$ of$ TRP$ receptors$ in$ nonYneuronal$ cells$
between$ experiments$ in$ cell$ culture$ and$ human$ studies$ is$ likely$ to$ be$ a$







the$ hypothesis$ that$ GOR$ results$ in$ cough$ through$ a$ vagallyYmediated$




This$study$did$demonstrate$small$ fold$ increases$ in$TRPVY1$expression$ in$both$
A549$and$BEASY2B$cell$types$in$response$to$pepsin$and$bile$salts,$however$there$
was$ no$ other$ clear$ trend$ in$ expression$ pattern$ seen$ and$ importantly$ no$
statistically$significant$change$in$TRP$receptor$expression$in$pulmonary$epithelial$
cells$ from$ the$central$ (BEASY2B)$or$distal$airways$ (A549).$The$ findings$of$ this$
study$therefore$do$not$support$the$hypothesis$that$the$individual$constituents$of$
gastric$ refluxate$ increase$ the$expression$of$TRP$ receptors$ in$airway$epithelial$
cells.$$
$
The$ importance$of$ the$small$ fold$ increases$as$a$ result$of$pepsin$and$bile$acid$







Although$ the$ study$ by$Mertens$ et$ al$ uses$ different$methodologies$ and$ posed$
different$ experimental$ questions$ the$ results$ can$ be$ used$ to$ help$ support$ and$












and$ ILY8$ secretion$ in$ these$ patients$ could$ be$ related$ to$ this,$ but$ as$ the$
inflammatory$response$was$higher$in$unYfiltered$gastric$juice$and$gastric$juice$on$



































innervation$ of$ the$ airways$ in$ patients$ with$ IPF,$ however$ has$ provided$ further$
evidence$ for$ central$ airways$ inflammationb$and$ for$ the$ first$ time$demonstrated$
TRPVY1$and$TRPAY1$gene$and$protein$expression$in$neuronal$and$nonYneuronal$
cells$of$airway$bronchial$biopsies$in$IPF.$In$relation$to$the$potential$role$of$GOR$
in$ IPFYassociated$ cough,$ the$ in$ vitro$ cell$ culture$ work$ used$ in$ this$ study$ has$
provided$an$insight$into$the$pathogenic$mechanisms$of$GOR$induced$cough$and$










This$ study$ has$ not$ shown$ evidence$ of$ a$ significant$ increase$ in$ TRPVY1$ and$
TRPAY1$gene$and$protein$expression$ in$ the$airways$of$patients$with$ IPF.$This$
suggests$that$a$structural$upYregulation$of$airway$TRP$receptors$alone$may$not$
be$ the$ mechanism$ for$ cough$ in$ IPF$ patients.$ However$ the$ evidence$ for$ a$




1.$ Physiological$ upYregulation$ of$ TRP$ receptors$ through$ sensitisation$may$
result$in$a$lower$threshold$for$initiation$of$an$action$potential$and$increased$
cough$reflex$sensitivity.$Although$there$was$no$significant$increase$in$TRP$
receptors,$ studies$suggest$ that$ small$ differences$ in$TRPVY1$expression$
may$result$in$large$differences$in$TRPVY1$sensitivity$through$the$release$
of$inflammatory$mediators$and$local$(peripheral)$sensitisation.$TRPAY1$is$









have$ been$ demonstrated$ at$ alveolar$ level$ (Watanabe$ et$ al.$ 2005),$ and$
although$ the$ peripheral$ CYfibres$ are$ thought$ to$ be$ inhibitory,$ there$ is$
evidence$ for$ increased$ expression$ of$ neurotrophins$ distally$ from$ BAL$




3.$ The$ lack$of$ correlation$between$TRP$ receptor$expression,$ cough$ reflex$
sensitivity$ and$ cough$ symptomatology$ raises$ the$ possibility$ that$ other$
components$of$the$cough$reflex$such$as$central$sensitisation$may$also$play$





causing$ cough$ in$ this$ condition.$ Age,$ gender,$ genetic$ susceptibility$ and$ the$


























































airways$of$patients$with$ IPF$and$control$ subjects.$Obtaining$biopsies$ from$ the$
parenchyma$of$patients$with$IPF$to$determine$whether$there$is$distal$structural$
TRP$ receptor$ upEregulation$ will$ be$ equally$ if$ not$ more$ difficult$ as$ with$ the$
improved$resolution$of$CT$scans$and$the$recognised$morbidity$associated$with$
surgical$ lung$biopsy,$ a$ tissue$biopsy$ is$ obtained$ less$ often$ than$previously$ to$




out$when$ there$ is$diagnostic$uncertainty$and$may$ therefore$ represent$patients$
with$ a$ different$ spectrum$ of$ disease.$ Ideally$ larger$ clinical$ studies$ would$ be$












antibodies$ to$ allow$ protein$ quantification,$ and$ a$ robust$ cell$ model$ to$ assess$
function$of$these$receptors$would$also$be$beneficial$to$aid$our$understanding$of$
the$role$of$these$receptors$within$the$cell.$Primary$lung$cells$would$allow$for$more$




clinical$ study$ would$ be$ ideal.$ This$ could$ involve$ comparing$ TRP$ receptor$
expression$in$oesophageal$biopsies$and$24$hour$pH$monitoring$and$impedance$
in$patients$with$IPF$against$control$patients.$However$an$alternative$study$could$
involve$ the$ oral$ administration$ of$ capsaicin$ in$ patients$ with$ IPF$ to$ determine$
whether$there$is$an$improvement$in$cough.$This$has$been$shown$to$be$effective$
in$ chronic$ cough$ and$ the$ authors$ postulate$ that$ the$ systemic$ absorption$ of$
capsaicin$ reduces$ cough$ reflex$ hypersensitivity$ in$ a$ mechanism$ of$ central$
desensitisation$(TernestenEHasseus$et$al.$2015),$however$others$argue$that$the$















molecular$ targets$will$ be$ discovered,$ such$ as$ the$ ASICs.$ Further$ research$ to$
develop$ primers$ and$ specific$ antibodies$ to$ detect$ and$ locate$ these$ receptors$
should$ improve$our$ understanding$of$ the$mechanisms$of$ cough$ in$ health$ and$







This$ research$ has$ been$ presented$ at$ the$ following$ local,$ regional$ and$
International$meetings:$
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•$ American$ Thoracic$ Society$ Poster$ presentation:$ Airway$ expression$ of$
Transient$Receptor$Potential$ channels$ in$ Idiopathic$Pulmonary$Fibrosis$
(May$2016)$
•$ American$Thoracic$Society$Poster$presentation:$Expression$of$Transient$










Patient$ Age$ Gender$ Smoking$status$ FVC$$ TLCO$ HRCT$
BAL$cell$differential$(%)$
M$ N$ L$ E$
1$ 75$ Male$ NonKsmoker$ 51.9$ 27.4$ UIP$pattern$ 88$ 2$ 9$ 1$
2$ 72$ Male$ NonKsmoker$ 74.0$ 33.6$ UIP$pattern$ 69$ 12$ 18$ 1$
3$ 72$ Male$ NonKsmoker$ 79.5$ 36.0$ UIP$pattern$
Neutrophil$predominantK$too$
scant$for$differential$$





















Patient$ Age$ Gender$ Smoking$status$ FVC$$ TLCO$$ HRCT$
BAL$cell$differential$(%)$



























92$ 8$ 0$ 0$
241$
$
Patient$ Age$ Gender$ Smoking$status$ FVC$$ TLCO$ HRCT$
BAL$cell$differential$(%)$













































































































































































































































































































































































































Mouse$tissue$(10mg)$ TRIzol$ 48.16$ 2.04$
Mouse$tissue$(10mg)$ ColumnEbased$ 27.47$ 1.99$
Pilot$sample$(15mg)$ TRIzol$ 70.9$ 2.03$
Pilot$sample$(15mg)$ ColumnEbased$ 50.9$ 1.94$
!










































































A549$ 100.00$ 102.00$ 105.13$ 111.28$ 90.40$ 34.71$
P"value" " 0.99" 0.99" 0.94" 0.97" 0.16"
BEASE2B$ 100.00$ 110.95$ 114.15$ 119.72$ 73.97$ 33.54$











A549$ 100.00$ 103.00$ 109.55$ 118.49$ 114.31$ 90.01$
P"value" " 0.99" 0.94" 0.93" 0.97" 0.93"
BEASE2B$ 100.00$ 108.42$ 111.49$ 107.88$ 105.90$ 39.96$







A549$ 100.00$ 127.59$ 112.13$ 84.76$ $ $
P"value" " 0.53" 0.91" 0.84" " $
BEASE2B$ 100.00$ 129.92$ 128.84$ 71.39$ $ $







A549$ 100.00$ 88.84$ 42.27$ 35.17$ $ $
P"value" " 0.96" 0.16" 0.10" " $
BEASE2B$ 100.00$ 130.11$ 35.49$ 34.65$ $ $
P"value" " 0.21" 0.01$ 0.01$ $ $
$ $
$ Control$ pH6$ pH4$ pH2$ $ $
A549$ 100.00$ 77.87$ 20.24$ 31.63$ $ $
P"value" " 0.90" 0.04$ 0.08$ $ $
BEASE2B$ 100.00$ 108.33$ 28.25$ 37.52$ $ $
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